#Coronavirus Disease #Research References (by AMEDEO, June 29 ’24)

  1. LIU X, Zheng M, Zhang H, Feng B, et al
    Characterization and noncovalent inhibition of the K63-deubiquitinase activity of SARS-CoV-2 PLpro.
    Antiviral Res. 2024 Jun 22:105944. doi: 10.1016/j.antiviral.2024.105944.
    PubMed         Abstract available
  2. POTTER JA, Aitken A, Yang L, Hill J, et al
    HEX17(Neumifil): an intranasal respiratory biotherapeutic with broad-acting antiviral activity.
    Antiviral Res. 2024 Jun 22:105945. doi: 10.1016/j.antiviral.2024.105945.
    PubMed         Abstract available
  3. BALIGA-GIL A, Soszynska-Jozwiak M, Ruszkowska A, Szczesniak I, et al
    Targeting sgRNA N secondary structure as a way of inhibiting SARS-CoV-2 replication.
    Antiviral Res. 2024 Jun 24:105946. doi: 10.1016/j.antiviral.2024.105946.
    PubMed         Abstract available


    BMJ
  4. LIMB M
    RCP president steps down “with immediate effect” after physician associates row.
    BMJ. 2024;385:q1383.
    PubMed        
  5. O’DOWD A
    RCGP calls for immediate freeze on recruitment of physician associates.
    BMJ. 2024;385:q1376.
    PubMed        
  6. LIMB M
    Covid-19: Study sheds light on how some people avoid the disease.
    BMJ. 2024;385:q1382.
    PubMed        
  7. HARGRAVE KL
    Long covid: I’d rather have a well researched and well informed doctor than “become my own physician”.
    BMJ. 2024;385:q1398.
    PubMed        
  8. RIMMER A
    How can I prepare for a general election?
    BMJ. 2024;385:q1371.
    PubMed        
  9. IACOBUCCI G
    Doctors are under attack from all sides, BMA chair tells annual meeting.
    BMJ. 2024;385:q1402.
    PubMed        
  10. DYER C
    Consultant tells court that fear of reprisal from management stopped him reporting Letby to police.
    BMJ. 2024;385:q1395.
    PubMed        
  11. DOWNS J, Baker S, Carnegie A
    Eating disorders: meeting the need for a data driven and coproduced response to pandemic disruption.
    BMJ. 2024;385:q1403.
    PubMed        
  12. MAHASE E, Rimmer A
    Doctors call for late rota penalties and for “consultant” to be protected title.
    BMJ. 2024;385:q1416.
    PubMed        
  13. IACOBUCCI G
    Manifesto health pledges from main parties are “unfunded commitments,” says IFS.
    BMJ. 2024;385:q1409.
    PubMed        
  14. EBIKEME C
    How Paris is preparing for the health threats of the Olympic Games.
    BMJ. 2024;385:q1263.
    PubMed        
  15. PATERLINI M
    Italy: Giving regions more power over healthcare will worsen inequalities, say critics.
    BMJ. 2024;385:q1415.
    PubMed        
  16. OLIVER D
    David Oliver: Will a Labour government rescue adult social care?
    BMJ. 2024;385:q1386.
    PubMed        
  17. COWPER A
    Unpicking the general election manifestos on health and care.
    BMJ. 2024;385:q1358.
    PubMed        
  18. HAM C
    The next government should support staff to improve care and increase investment.
    BMJ. 2024;385:q1423.
    PubMed        
  19. RICKENBACH M
    Reframing the “heartsink” feeling can help doctors find a resolution.
    BMJ. 2024;385:q1427.
    PubMed        

  20. Seven days in medicine: 19-25 June 2024.
    BMJ. 2024;385:q1399.
    PubMed        
  21. BUSE K, McKee M
    What next for UK development assistance under the next government?
    BMJ. 2024;385:q1392.
    PubMed        


    Clin Infect Dis
  22. SISE ME, Santos JR, Goldman JD, Tuttle KR, et al
    Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial.
    Clin Infect Dis. 2024 Jun 24:ciae333. doi: 10.1093.
    PubMed         Abstract available
  23. ZENG G, Zhou Y
    Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection.
    Clin Infect Dis. 2024 Jun 26:ciae342. doi: 10.1093.
    PubMed        
  24. FUSCO D, Malenica I, Gunthard HF, Gupta SK, et al
    Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison from Two Large, Open-Label Studies.
    Clin Infect Dis. 2024 Jun 26:ciae336. doi: 10.1093.
    PubMed         Abstract available
  25. CHONG C, Wee LE, Jin X, Zhang M, et al
    Risks of SARS-CoV-2 JN.1 infection and COVID-19 associated emergency-department (ED) visits/hospitalizations following updated boosters and prior infection: a population-based cohort study.
    Clin Infect Dis. 2024 Jun 26:ciae339. doi: 10.1093.
    PubMed         Abstract available

  26. Rapid Guidelines to Address the Changing COVID-19 Pandemic.
    Clin Infect Dis. 2024;78:e81-e82.
    PubMed        


    Emerg Infect Dis
  27. OGATA T, Tanaka H, Kon A, Sakaibori N, et al
    Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2-Dominant Period, Japan.
    Emerg Infect Dis. 2024;30:1430-1433.
    PubMed         Abstract available
  28. BARAK MEM, Wu S, Luria G, Schnyder LP, et al
    Engaging Communities in Emerging Infectious Disease Mitigation to Improve Public Health and Safety.
    Emerg Infect Dis. 2024;30:1390-1397.
    PubMed         Abstract available
  29. IBA A, Hosozawa M, Hori M, Muto Y, et al
    Prevalence of and Risk Factors for Post-COVID-19 Condition during Omicron BA.5-Dominant Wave, Japan.
    Emerg Infect Dis. 2024;30:1380-1389.
    PubMed         Abstract available
  30. FESS LJ, Fell A, O’Toole S, D’Heilly P, et al
    COVID-19 Death Determination Methods, Minnesota, USA, 2020-2022(1).
    Emerg Infect Dis. 2024;30:1352-1360.
    PubMed         Abstract available
  31. KIIZA D, Semanda JN, Kawere BB, Ajore C, et al
    Strategies to Enhance COVID-19 Vaccine Uptake among Prioritized Groups, Uganda-Lessons Learned and Recommendations for Future Pandemics.
    Emerg Infect Dis. 2024;30:1326-1334.
    PubMed         Abstract available


    Int J Infect Dis
  32. CHOI YJ, Kim HN, Lee J, Nham E, et al
    Erythema nodosum as an unusual skin manifestation of long COVID: A case report.
    Int J Infect Dis. 2024 Jun 25:107152. doi: 10.1016/j.ijid.2024.107152.
    PubMed         Abstract available
  33. HASEGAWA J, Sekizawa A, Tanaka H, Katsuragi S, et al
    Infection route associated with invasive group A streptococcal toxic shock syndrome in maternal deaths: Nationwide analysis of maternal mortalities in Japan.
    Int J Infect Dis. 2024 Jun 25:107154. doi: 10.1016/j.ijid.2024.107154.
    PubMed         Abstract available
  34. WAN EYF, Wang B, Lee AL, Zhou J, et al
    Comparative Effectiveness and Safety of BNT162b2 and CoronaVac in Hong Kong: A Target Trial Emulation.
    Int J Infect Dis. 2024 Jun 21:107149. doi: 10.1016/j.ijid.2024.107149.
    PubMed         Abstract available
  35. JEDLICKA P
    Furst et al. fail to address crucial biases other than the Healthy vaccinee effect.
    Int J Infect Dis. 2024 Jun 20:107143. doi: 10.1016/j.ijid.2024.107143.
    PubMed        
  36. SMID M, Tucek V, Madar R, Tachezy R, et al
    No evidence of a “healthy vaccinee effect” in COVID-19 vaccination data from the Czech Republic.
    Int J Infect Dis. 2024 Jun 19:107144. doi: 10.1016/j.ijid.2024.107144.
    PubMed        


    Intensive Care Med
  37. APPIAH JA, Barth A, McGloughlin S, Cecconi M, et al
    Global impact: WHO and ESICM collaboration in launching the COVID-19 skills preparation course.
    Intensive Care Med. 2024 Jun 25. doi: 10.1007/s00134-024-07469.
    PubMed        


    J Infect
  38. CHAKA A, Pan D, Irshad M, Piranie H, et al
    Inclusion of racial and ethnic groups in clinical trials for COVID-19 and post-acute COVID-19 syndrome: an analysis of studies registered on ClinicalTrials.gov.
    J Infect. 2024 Jun 20:106207. doi: 10.1016/j.jinf.2024.106207.
    PubMed        
  39. GONG X, Peng L, Wang F, Liu J, et al
    Repeated Omicron infection dampens immune imprinting from previous vaccination and induces broad neutralizing antibodies against Omicron sub-variants.
    J Infect. 2024;89:106208.
    PubMed         Abstract available
  40. PEREZ-GARCIA C, Sempere J, de Miguel S, Hita S, et al
    Surveillance of invasive pneumococcal disease in Spain exploring the impact of the COVID-19 pandemic (2019-2023).
    J Infect. 2024;89:106204.
    PubMed         Abstract available


    J Med Virol
  41. GALLEGO-GARCIA P, Estevez-Gomez N, De Chiara L, Alvarino P, et al
    Dispersal history of SARS-CoV-2 in Galicia, Spain.
    J Med Virol. 2024;96:e29773.
    PubMed         Abstract available
  42. MALLICK A, Sukla S, De A, Biswas S, et al
    Evidences support that dengue virus can impart broad-spectrum immunity against betacoronaviruses in dengue endemic regions.
    J Med Virol. 2024;96:e29771.
    PubMed         Abstract available
  43. XIAO M, Banu A, Jia Y, Chang M, et al
    Circulation pattern and genetic variation of rhinovirus infection among hospitalized children on Hainan Island, before and after the dynamic zero-COVID policy, from 2021 to 2023.
    J Med Virol. 2024;96:e29755.
    PubMed         Abstract available


    J Virol
  44. PECHOUS RD, Malaviarachchi PA, Banerjee SK, Byrum SD, et al
    An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy.
    J Virol. 2024 Jun 28:e0079424. doi: 10.1128/jvi.00794.
    PubMed         Abstract available
  45. ZHAO J, Huang Y, Liukang C, Yang R, et al
    Dissecting infectious bronchitis virus-induced host shutoff at the translation level.
    J Virol. 2024 Jun 28:e0083024. doi: 10.1128/jvi.00830.
    PubMed         Abstract available


    JAMA
  46. WEN X, Yan J, Zhu Z
    Apixaban to Prevent Recurrence After Cryptogenic Stroke.
    JAMA. 2024 May 13. doi: 10.1001/jama.2024.6848.
    PubMed        


    Lancet
  47. SCHRECKER T
    Canada’s reckoning?
    Lancet. 2024;403:2688.
    PubMed        


    Lancet Infect Dis
  48. BUERANO CC, Morita K
    Single dose of Dengvaxia vaccine: is it a cause for alarm?
    Lancet Infect Dis. 2024;24:670-671.
    PubMed        
  49. DUNSMUIR H
    Managing loss during the COVID-9 pandemic.
    Lancet Infect Dis. 2024;24:683.
    PubMed        
  50. GEERS D, Gommers L, Tan NH, Bogers S, et al
    Profiling the SARS-CoV-2-specific T-cell response.
    Lancet Infect Dis. 2024 Jun 20:S1473-3099(24)00377.
    PubMed        


    Life Sci
  51. RAHEEM MA, Rahim MA, Gul I, Reyad-Ul-Ferdous M, et al
    COVID-19: Post infection implications in different age groups, mechanism, diagnosis, effective prevention, treatment, and recommendations.
    Life Sci. 2024 Jun 24:122861. doi: 10.1016/j.lfs.2024.122861.
    PubMed         Abstract available


    N Engl J Med
  52. CHEHADE M, Dellon ES, Spergel JM, Collins MH, et al
    Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age.
    N Engl J Med. 2024;390:2239-2251.
    PubMed         Abstract available


    Nature
  53. MILKMAN KL, Ellis SF, Gromet DM, Jung Y, et al
    Megastudy shows that reminders boost vaccination but adding free rides does not.
    Nature. 2024 Jun 26. doi: 10.1038/s41586-024-07591.
    PubMed         Abstract available


    Science
  54. WADMAN M
    Plans for U.S. bat lab spark outbreak fears.
    Science. 2024;384:1392-1393.
    PubMed         Abstract available
  55. LAXMINARAYAN R, Gleason A, Sheen J, Saad-Roy CM, et al
    Unlock the potential of vaccines in food-producing animals.
    Science. 2024;384:1409-1411.
    PubMed         Abstract available

#Influenza and Other Respiratory Viruses #Research #References (by AMEDEO, June 29 ’24)

  1. XU J, Zhu Q, Li W, Yin X, et al
    Structural basis for the inhibition of the HCoV-NL63 main protease M(pro) by X77.
    Biochem Biophys Res Commun. 2024;724:150231.
    PubMed         Abstract available
  2. LI Q, Zhou X, Wang W, Xu Q, et al
    Structural basis of rosmarinic acid inhibitory mechanism on SARS-CoV-2 main protease.
    Biochem Biophys Res Commun. 2024;724:150230.
    PubMed         Abstract available


    Biochem Soc Trans
  3. WATKINS JM, Burke JM
    A closer look at mammalian antiviral condensates.
    Biochem Soc Trans. 2024;52:1393-1404.
    PubMed         Abstract available


    BMJ
  4. LIMB M
    RCP president steps down “with immediate effect” after physician associates row.
    BMJ. 2024;385:q1383.
    PubMed        
  5. O’DOWD A
    RCGP calls for immediate freeze on recruitment of physician associates.
    BMJ. 2024;385:q1376.
    PubMed        
  6. LIMB M
    Covid-19: Study sheds light on how some people avoid the disease.
    BMJ. 2024;385:q1382.
    PubMed        
  7. HARGRAVE KL
    Long covid: I’d rather have a well researched and well informed doctor than “become my own physician”.
    BMJ. 2024;385:q1398.
    PubMed        
  8. RIMMER A
    How can I prepare for a general election?
    BMJ. 2024;385:q1371.
    PubMed        
  9. IACOBUCCI G
    Doctors are under attack from all sides, BMA chair tells annual meeting.
    BMJ. 2024;385:q1402.
    PubMed        
  10. DYER C
    Consultant tells court that fear of reprisal from management stopped him reporting Letby to police.
    BMJ. 2024;385:q1395.
    PubMed        
  11. DOWNS J, Baker S, Carnegie A
    Eating disorders: meeting the need for a data driven and coproduced response to pandemic disruption.
    BMJ. 2024;385:q1403.
    PubMed        
  12. MAHASE E, Rimmer A
    Doctors call for late rota penalties and for “consultant” to be protected title.
    BMJ. 2024;385:q1416.
    PubMed        
  13. IACOBUCCI G
    Manifesto health pledges from main parties are “unfunded commitments,” says IFS.
    BMJ. 2024;385:q1409.
    PubMed        
  14. EBIKEME C
    How Paris is preparing for the health threats of the Olympic Games.
    BMJ. 2024;385:q1263.
    PubMed        
  15. PATERLINI M
    Italy: Giving regions more power over healthcare will worsen inequalities, say critics.
    BMJ. 2024;385:q1415.
    PubMed        
  16. OLIVER D
    David Oliver: Will a Labour government rescue adult social care?
    BMJ. 2024;385:q1386.
    PubMed        
  17. COWPER A
    Unpicking the general election manifestos on health and care.
    BMJ. 2024;385:q1358.
    PubMed        
  18. HAM C
    The next government should support staff to improve care and increase investment.
    BMJ. 2024;385:q1423.
    PubMed        
  19. RICKENBACH M
    Reframing the “heartsink” feeling can help doctors find a resolution.
    BMJ. 2024;385:q1427.
    PubMed        

  20. Seven days in medicine: 19-25 June 2024.
    BMJ. 2024;385:q1399.
    PubMed        
  21. MAHASE E
    Pregnant women and older adults in England and Scotland to be offered RSV vaccination.
    BMJ. 2024;385:q1436.
    PubMed        
  22. BUSE K, McKee M
    What next for UK development assistance under the next government?
    BMJ. 2024;385:q1392.
    PubMed        


    J Exp Med
  23. MCINTIRE KM, Meng H, Lin TH, Kim W, et al
    Maturation of germinal center B cells after influenza virus vaccination in humans.
    J Exp Med. 2024;221:e20240668.
    PubMed         Abstract available


    J Gen Virol
  24. BORDES L, Gerhards NM, Peters S, van Oort S, et al
    H5N1 clade 2.3.4.4b avian influenza viruses replicate in differentiated bovine airway epithelial cells cultured at air-liquid interface.
    J Gen Virol. 2024;105.
    PubMed         Abstract available


    J Infect Dis
  25. ANANWORANICH J, Lee IT, Ensz D, Carmona L, et al
    Safety and Immunogenicity of mRNA-1010, an Investigational Seasonal Influenza Vaccine, in Healthy Adults: Final Results From a Phase 1/2 Randomized Trial.
    J Infect Dis. 2024 Jun 27:jiae329. doi: 10.1093.
    PubMed         Abstract available


    J Virol
  26. YU X, Tian J, Wang Y, Su N, et al
    The pseudogene GBP1P1 suppresses influenza A virus replication by acting as a protein decoy for DHX9.
    J Virol. 2024 Jun 28:e0073824. doi: 10.1128/jvi.00738.
    PubMed         Abstract available


    JAMA
  27. SCRUGGS-WODKOWSKI EA, Malani PN, Linder KA
    Therapies to Decrease Severe Respiratory Syncytial Virus Illness.
    JAMA. 2024;331:2127-2128.
    PubMed        
  28. WEN X, Yan J, Zhu Z
    Apixaban to Prevent Recurrence After Cryptogenic Stroke.
    JAMA. 2024 May 13. doi: 10.1001/jama.2024.6848.
    PubMed        


    Lancet
  29. SCHRECKER T
    Canada’s reckoning?
    Lancet. 2024;403:2688.
    PubMed        


    PLoS Comput Biol
  30. SHUBIN M, Brustad HK, Midtbo JE, Gunther F, et al
    The influence of cross-border mobility on the COVID-19 epidemic in Nordic countries.
    PLoS Comput Biol. 2024;20:e1012182.
    PubMed         Abstract available


    PLoS One
  31. YERKES MA, Besamusca J, van der Zwan R, Andre S, et al
    Gender inequality in work location, childcare and work-life balance: Phase-specific differences throughout the COVID-19 pandemic.
    PLoS One. 2024;19:e0302633.
    PubMed         Abstract available
  32. STEVENS ER, Feldstein D, Jones S, Twan C, et al
    Ambulatory antibiotic prescription rates for acute respiratory infection rebound two years after the start of the COVID-19 pandemic.
    PLoS One. 2024;19:e0306195.
    PubMed         Abstract available
  33. WERDIN S, Neufeind J
    The implementation of a new measles vaccine mandate in Germany: A qualitative study in local health departments.
    PLoS One. 2024;19:e0306003.
    PubMed         Abstract available
  34. VOLPE M, Ralli M, Isidori A
    “The impact of the COVID-19 pandemic on research activities: A survey of the largest Italian academic community”.
    PLoS One. 2024;19:e0304078.
    PubMed         Abstract available
  35. HACKMAN HK, Annison L, Arhin RE, Adjei GO, et al
    Self-medication with antibiotics during the COVID-19 pandemic: A cross-sectional study among adults in Tema, Ghana.
    PLoS One. 2024;19:e0305602.
    PubMed         Abstract available
  36. BOTELHO RO, Coelho CCF, Andrade EF, Castelo PM, et al
    Fear of the COVID-19 vaccine in a public healthcare system and university setting.
    PLoS One. 2024;19:e0304000.
    PubMed         Abstract available
  37. CLEMENTS N, Diel DG, Elvinger F, Koretzky G, et al
    The role of veterinary diagnostic laboratories during COVID-19 response in the United States.
    PLoS One. 2024;19:e0303019.
    PubMed         Abstract available
  38. CARLOCK MA, Allen JD, Hanley HB, Ross TM, et al
    Longitudinal assessment of human antibody binding to hemagglutinin elicited by split-inactivated influenza vaccination over six consecutive seasons.
    PLoS One. 2024;19:e0301157.
    PubMed         Abstract available
  39. APOUEY B, Yin R, Etile F, Piper A, et al
    Mental health and the overall tendency to follow official recommendations against COVID-19: A U-shaped relationship?
    PLoS One. 2024;19:e0305833.
    PubMed         Abstract available
  40. NABI KN, Ovi MA, Kabir KMA
    Analyzing evolutionary game theory in epidemic management: A study on social distancing and mask-wearing strategies.
    PLoS One. 2024;19:e0301915.
    PubMed         Abstract available
  41. AKRONG GB, Hiadzi RA, Donkor AB, Anafo DK, et al
    COVID-19 vaccine acceptance and hesitancy in Ghana: A systematic review.
    PLoS One. 2024;19:e0305993.
    PubMed         Abstract available
  42. KE HL, Li RJ, Yu CC, Wang XP, et al
    Network pharmacology and experimental verification to decode the action of Qing Fei Hua Xian Decotion against pulmonary fibrosis.
    PLoS One. 2024;19:e0305903.
    PubMed         Abstract available
  43. YU H, Bonett S, Oyiborhoro U, Aryal S, et al
    Psychosocial correlates of parents’ willingness to vaccinate their children against COVID-19.
    PLoS One. 2024;19:e0305877.
    PubMed         Abstract available
  44. THANH NH, Manh Hung T, Ngoc TN, San BV, et al
    Demand for mental health support services among health professionals in Vietnam: Lesson from COVID-19 Pandemic.
    PLoS One. 2024;19:e0305869.
    PubMed         Abstract available
  45. MOSKOWITZ JT, Jackson KL, Cummings P, Addington EL, et al
    Feasibility, acceptability, and efficacy of a positive emotion regulation intervention to promote resilience for healthcare workers during the COVID-19 pandemic: A randomized controlled trial.
    PLoS One. 2024;19:e0305172.
    PubMed         Abstract available
  46. FERRIS BF, Balasubramanian S, Rajamanickam A, Munisankar S, et al
    Relative contribution of biomedical, demographic, and socioeconomic factors to COVID-19 vaccine receipt in rural India.
    PLoS One. 2024;19:e0305819.
    PubMed         Abstract available
  47. HUO X, Zhao Y, Dong Z
    How mixed ownership affects investment efficiency? evidence from state-owned enterprises in China.
    PLoS One. 2024;19:e0306190.
    PubMed         Abstract available
  48. ZHONG B, Sun H, Wang G, Junwen S, et al
    Physical activity on the mental health of children and adolescents during COVID-19 pandemic-induced school closures-A systematic review.
    PLoS One. 2024;19:e0299158.
    PubMed         Abstract available
  49. URE SL, Gill C, Evans T, Windsor TD, et al
    Engage! a pilot study of a brief behavioural activation program to promote engagement and well-being in older adults.
    PLoS One. 2024;19:e0305908.
    PubMed         Abstract available
  50. SCARFE P, Watcham K, Clarke A, Roesch E, et al
    A real-world test of artificial intelligence infiltration of a university examinations system: A “Turing Test” case study.
    PLoS One. 2024;19:e0305354.
    PubMed         Abstract available
  51. BROUGHAN J, Sietins E, Emily Siu KY, Clendennen N, et al
    Enhancing long COVID care in general practice: A qualitative study.
    PLoS One. 2024;19:e0306077.
    PubMed         Abstract available
  52. REUSCHKE D, Houston D, Sissons P
    Impacts of Long COVID on workers: A longitudinal study of employment exit, work hours and mental health in the UK.
    PLoS One. 2024;19:e0306122.
    PubMed         Abstract available
  53. LIU G, Liu Q, Guo H, Xiang M, et al
    Optimization of “vehicle-UAV” joint distribution routing for cold chain logistics considering risk of epidemic spreading and green cost.
    PLoS One. 2024;19:e0306127.
    PubMed         Abstract available
  54. BEADLE ES, Walecka A, Sangam AV, Moorhouse J, et al
    Triggers and factors associated with moral distress and moral injury in health and social care workers: A systematic review of qualitative studies.
    PLoS One. 2024;19:e0303013.
    PubMed         Abstract available
  55. BARTOSZEWICZ K, Bartoszewicz M, Gradkowski W, Stroz S, et al
    Analysis of prognostic factors in critically ill patients with COVID-19.
    PLoS One. 2024;19:e0302248.
    PubMed         Abstract available
  56. MOJAHED A, Mack JT, Staudt A, Weise V, et al
    Prevalence and risk factors of intimate partner violence during the COVID-19 pandemic: Results from the population-based study DREAMCORONA.
    PLoS One. 2024;19:e0306103.
    PubMed         Abstract available


    Vaccine
  57. CHATZILENA A, Hyams C, Challen R, Marlow R, et al
    Winter 2022-23 influenza vaccine effectiveness against influenza-related hospitalised aLRTD: A test-negative, case-control study.
    Vaccine. 2024 Jun 24:S0264-410X(24)00713-8. doi: 10.1016/j.vaccine.2024.
    PubMed        
  58. YOO YM, Katz MA, Greenberg D, Marcenac P, et al
    Knowledge, attitudes, and practices associated with influenza vaccine uptake among healthcare personnel in Israel during three influenza seasons, 2016-2019.
    Vaccine. 2024 Jun 25:S0264-410X(24)00705-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  59. COULIBALY D, Douba A, N’Guessan K, N’Gattia AK, et al
    Intent to receive flu vaccine and influenza vaccination coverage among health professionals during 2019, 2020 and 2021 campaigns in Cote d’Ivoire.
    Vaccine. 2024 Jun 25:S0264-410X(24)00717-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virology
  60. HUANG J, Ma K, Zhang J, Zhou J, et al
    Pathogenicity and transmission of novel highly pathogenic H7N2 variants originating from H7N9 avian influenza viruses in chickens.
    Virology. 2024;597:110121.
    PubMed         Abstract available


    Virus Res
  61. LEIST SR, Schafer A, Risemberg EL, Bell TA, et al
    Sarbecovirus disease susceptibility is conserved across viral and host models.
    Virus Res. 2024;346:199399.
    PubMed         Abstract available
  62. TAKADATE Y, Mine J, Tsunekuni R, Sakuma S, et al
    Genetic diversity of H5N1 and H5N2 high pathogenicity avian influenza viruses isolated from poultry in Japan during the winter of 2022-2023.
    Virus Res. 2024;347:199425.
    PubMed         Abstract available

#Coronavirus Disease Research #References (by AMEDEO.com, June 22 ’24)


  1. Correction: Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19.
    Ann Intern Med. 2024 Jun 18. doi: 10.7326/ANNALS-24-00699.
    PubMed        


    Antiviral Res
  2. DICKEY TH, Salinas ND, Patel P, Orr-Gonzalez S, et al
    RBD design increases the functional antibody titers elicited by SARS-CoV-2 spike vaccination.
    Antiviral Res. 2024 Jun 18:105937. doi: 10.1016/j.antiviral.2024.105937.
    PubMed         Abstract available


    BMJ
  3. MORGAN J
    “I wasn’t alone after all”-how modelling vulnerability can support staff wellbeing.
    BMJ. 2024;385:q1313.
    PubMed        
  4. ALKHALDI M
    Call to boost the profile of the Middle East and north Africa region in global health.
    BMJ. 2024;385:q1272.
    PubMed        
  5. LIMB M
    Election watch: How credible are the main parties’ pledges on the NHS?
    BMJ. 2024;385:q1320.
    PubMed        
  6. OXTOBY K
    Why I . . . go adventure sailing.
    BMJ. 2024;385:q1292.
    PubMed        
  7. IRWIN EM
    Knock, knock. Who’s there? It’s the senior house officers trying to come back . .
    BMJ. 2024;385:q1343.
    PubMed        
  8. POLKINGHORN A
    Thank you for waiting.
    BMJ. 2024;385:q1295.
    PubMed        
  9. FEINMANN J
    Analysis reveals global post-covid surge in infectious diseases.
    BMJ. 2024;385:q1348.
    PubMed        
  10. LAUNER J
    John Launer: Faces or candlesticks? Why we need continuity in teams.
    BMJ. 2024;385:q1323.
    PubMed        
  11. O’DOWD A
    World is woefully unprepared for another pandemic, experts warn.
    BMJ. 2024;385:q1355.
    PubMed        
  12. OLIVER D
    David Oliver: Will the actions pledged in Labour’s election manifesto save health and social care?
    BMJ. 2024;385:q1326.
    PubMed        
  13. BUSE K, McKee M
    UK political parties pledge to strengthen security-yet ignore health security.
    BMJ. 2024;385:q1359.
    PubMed        
  14. ENRIA L, Dwyer H, Marchant M, Beckmann N, et al
    Political dimensions of misinformation, trust, and vaccine confidence in a digital age.
    BMJ. 2024;385:e079940.
    PubMed        
  15. VISWANATH K, Lee EJ, Dryer E
    Communication inequalities and incomplete data hinder understanding of how social media affect vaccine uptake.
    BMJ. 2024;385:e076478.
    PubMed        
  16. FEINMANN J
    GP who confronted Rishi Sunak received “hundreds” of supportive messages from doctors.
    BMJ. 2024;385:q1375.
    PubMed        
  17. LIMB M
    Avoidable mortality in England and Wales remains higher than before pandemic, data show.
    BMJ. 2024;385:q1370.
    PubMed        
  18. IACOBUCCI G
    Junior doctors offer prime minister “final chance” to avoid pre-election strike.
    BMJ. 2024;385:q1367.
    PubMed        


    Int J Infect Dis
  19. FARMER G, Sikdar KC, Lo T, Conly J, et al
    Real-world evidence of sotrovimab effectiveness for preventing severe outcomes in patients with COVID-19: A quality improvement propensity matched retrospective cohort study of a pan-provincial program in Alberta, Canada.
    Int J Infect Dis. 2024 Jun 14:107136. doi: 10.1016/j.ijid.2024.107136.
    PubMed         Abstract available
  20. HUIBERTS AJ, van den Hof S, Knol MJ
    Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection: repeat analyses with updated data for the prospective cohort study in the Netherlands from July 2021 to June 2022.
    Int J Infect Dis. 2024 Jun 18:107127. doi: 10.1016/j.ijid.2024.107127.
    PubMed        


    J Infect
  21. MIKOLAJCZYK R, Diexer S, Klee B, Pfrommer L, et al
    Likelihood of Post-COVID Condition in people with hybrid immunity; data from the German National Cohort (NAKO).
    J Infect. 2024 Jun 17:106206. doi: 10.1016/j.jinf.2024.106206.
    PubMed         Abstract available
  22. KAJIHARA T, Yahara K, Kamigaki T, Hirabayashi A, et al
    Effects of coronavirus disease 2019 on the spread of respiratory-transmitted human-to-human bacteria.
    J Infect. 2024 Jun 17:106201. doi: 10.1016/j.jinf.2024.106201.
    PubMed         Abstract available
  23. LIU B, Xu L, Ma Y, Wang H, et al
    Evidence of immunity gap: Decline in antibodies against M. pneumoniae during the COVID-19 pandemic.
    J Infect. 2024 Jun 18:106209. doi: 10.1016/j.jinf.2024.106209.
    PubMed        


    J Med Virol
  24. BLANGY-LETHEULE A, Vergnaud A, Dupas T, Habert D, et al
    Value of a secretomic approach for distinguishing patients with COVID-19 viral pneumonia among patients with respiratory distress admitted to intensive care unit.
    J Med Virol. 2024;96:e29756.
    PubMed         Abstract available
  25. ALMANZAR G, Koosha K, Vogt T, Stein A, et al
    Hybrid immunity by two COVID-19 mRNA vaccinations and one breakthrough infection provides a robust and balanced cellular immune response as basic immunity against severe acute respiratory syndrome coronavirus 2.
    J Med Virol. 2024;96:e29739.
    PubMed         Abstract available
  26. TANG Y, Zou X, Liu P, Dai Y, et al
    Human umbilical cord-derived mesenchymal stem cell transplantation improves the long COVID.
    J Med Virol. 2024;96:e29757.
    PubMed         Abstract available
  27. KARBIENER M, Kindle G, Meyts I, Seppanen MRJ, et al
    Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency.
    J Med Virol. 2024;96:e29738.
    PubMed         Abstract available
  28. ZHU W, Gu L
    Resurgence of seasonal influenza driven by A/H3N2 and B/Victoria in succession during the 2023-2024 season in Beijing showing increased population susceptibility.
    J Med Virol. 2024;96:e29751.
    PubMed         Abstract available


    J Virol
  29. CHEN Z, Cui Q, Ran Y, Achi JG, et al
    A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation.
    J Virol. 2024 Jun 20:e0050424. doi: 10.1128/jvi.00504.
    PubMed         Abstract available
  30. STAHL-HENNIG C, Peter AS, Cordsmeier A, Stolte-Leeb N, et al
    Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model.
    J Virol. 2024 Jun 20:e0062824. doi: 10.1128/jvi.00628.
    PubMed         Abstract available
  31. PAN R, Li P, Meyerholz DK, Perlman S, et al
    Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice.
    J Virol. 2024 Jun 18:e0058424. doi: 10.1128/jvi.00584.
    PubMed         Abstract available


    JAMA
  32. ZIMBROFF RM, Deardorff WJ, Song S, Nikolov MC, et al
    Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound Older Adults.
    JAMA. 2024 Jun 20. doi: 10.1001/jama.2024.9673.
    PubMed        
  33. HARRIS E
    Lower Dose of Mpox Vaccine Was Safe, Effective.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
    PubMed        
  34. HARRIS E
    Microneedle Vaccine Patches Generated Immune Response in Children.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8629.
    PubMed        


    Lancet
  35. ZAROCOSTAS J
    Mental health in emergencies requires “a major rethink”.
    Lancet. 2024;403:2582.
    PubMed        
  36. THE LANCET
    Taking persistent physical symptoms seriously.
    Lancet. 2024;403:2565.
    PubMed        
  37. YOON JH, Kwon IH, Park HW
    The South Korean health-care system in crisis.
    Lancet. 2024;403:2589.
    PubMed        
  38. KUNKLER I
    Improving future UK pandemic management structure.
    Lancet. 2024;403:2592.
    PubMed        
  39. SAMARASEKERA U
    African vaccine manufacturing scheme to boost production.
    Lancet. 2024;403:2579-2580.
    PubMed        
  40. AHSAN S
    Israel border closure denying health care to Gazans.
    Lancet. 2024;403:2581.
    PubMed        


    N Engl J Med
  41. SAMET JH, El-Bassel N, Winhusen TJ, Jackson RD, et al
    Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths.
    N Engl J Med. 2024 Jun 16. doi: 10.1056/NEJMoa2401177.
    PubMed         Abstract available


    Nature
  42. LINDEBOOM RGH, Worlock KB, Dratva LM, Yoshida M, et al
    Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.
    Nature. 2024 Jun 19. doi: 10.1038/s41586-024-07575.
    PubMed         Abstract available
  43. ISRAELOW B, Iwasaki A
    First encounter with SARS-CoV-2: immune portraits of COVID susceptibility.
    Nature. 2024 Jun 19. doi: 10.1038/d41586-024-01644.
    PubMed        
  44. NURSE P
    We can make the UK a science superpower – with a radical political manifesto.
    Nature. 2024;630:532.
    PubMed        
  45. RIVA L, Yuan S, Yin X, Martin-Sancho L, et al
    Author Correction: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.
    Nature. 2024 Jun 18. doi: 10.1038/s41586-024-07659.
    PubMed        
  46. KULKARNI S
    AI and Euro 2024: VAR is shaking up football – and it’s not going away.
    Nature. 2024;630:538-539.
    PubMed        
  47. CASTELVECCHI D
    CERN’s $17-billion supercollider in question as top funder criticizes cost.
    Nature. 2024;630:539-540.
    PubMed        

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO.com, June 22 ’24)

  1. AMERATUNGA R, Jordan A, Lehnert K, Leung E, et al
    SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?
    Antiviral Res. 2024 Apr 25:105894. doi: 10.1016/j.antiviral.2024.105894.
    PubMed         Abstract available
  2. SUN Y, Wagatsuma K, Saito R, Sato I, et al
    Duration of fever in children infected with influenza A(H1N1)pdm09, A(H3N2) or B virus and treated with baloxavir marboxil, oseltamivir, laninamivir, or zanamivir in Japan during the 2012-2013 and 2019-2020 influenza seasons.
    Antiviral Res. 2024 Jun 17:105938. doi: 10.1016/j.antiviral.2024.105938.
    PubMed         Abstract available
  3. LE UNP, Chang YJ, Lu CH, Chen Y, et al
    Glycyrrhizic acid conjugates with amino acid methyl esters target the main protease, exhibiting antiviral activity against wild-type and nirmatrelvir-resistant SARS-CoV-2 variants.
    Antiviral Res. 2024;227:105920.
    PubMed         Abstract available
  4. LIANG Y, Xiao W, Peng Y, Zhang S, et al
    Development of Nanoparticle Vaccines Utilizing Designed Fc-Binding Homo-oligomers and RBD-Fc of SARS-CoV-2.
    Antiviral Res. 2024 May 21:105917. doi: 10.1016/j.antiviral.2024.105917.
    PubMed         Abstract available
  5. BONNEUX B, Shareef A, Tcherniuk S, Anson B, et al
    JNJ-7184, a respiratory syncytial virus inhibitor targeting the connector domain of the viral polymerase.
    Antiviral Res. 2024;227:105907.
    PubMed         Abstract available
  6. HUANG J, Wang W, Li H, Bai Y, et al
    Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2.
    Antiviral Res. 2024;227:105905.
    PubMed         Abstract available
  7. PANDEY K, Acharya A, Pal D, Jain P, et al
    SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2.
    Antiviral Res. 2024;227:105904.
    PubMed         Abstract available
  8. SALGADO-BENVINDO C, Tas A, Zevenhoven-Dobbe JC, van der Meer Y, et al
    Characterization of SARS-CoV-2 replication in human H1299/ACE2 cells: a versatile and practical infection model for antiviral research and beyond.
    Antiviral Res. 2024 May 7:105903. doi: 10.1016/j.antiviral.2024.105903.
    PubMed         Abstract available


    Biochemistry (Mosc)
  9. AFRIDONOVA ZE, Toptygina AP, Mikhaylov IS
    Humoral and Cellular Immune Response to SARS-CoV-2 S and N Proteins.
    Biochemistry (Mosc). 2024;89:872-882.
    PubMed         Abstract available
  10. ASTAKHOVA EA, Morozov AA, Vavilova JD, Filatov AV, et al
    Antigenic Cartography of SARS-CoV-2.
    Biochemistry (Mosc). 2024;89:862-871.
    PubMed         Abstract available


    BMC Pediatr
  11. UPPALA R, Seenoikhao N, Sitthikarnkha P, Niamsanit S, et al
    Clinical characteristics and prognostic marker for hospitalization in children with influenza infection in an emergency setting.
    BMC Pediatr. 2024;24:399.
    PubMed         Abstract available


    BMJ
  12. MORGAN J
    “I wasn’t alone after all”-how modelling vulnerability can support staff wellbeing.
    BMJ. 2024;385:q1313.
    PubMed        
  13. ALKHALDI M
    Call to boost the profile of the Middle East and north Africa region in global health.
    BMJ. 2024;385:q1272.
    PubMed        
  14. LIMB M
    Election watch: How credible are the main parties’ pledges on the NHS?
    BMJ. 2024;385:q1320.
    PubMed        
  15. OXTOBY K
    Why I . . . go adventure sailing.
    BMJ. 2024;385:q1292.
    PubMed        
  16. IRWIN EM
    Knock, knock. Who’s there? It’s the senior house officers trying to come back . .
    BMJ. 2024;385:q1343.
    PubMed        
  17. POLKINGHORN A
    Thank you for waiting.
    BMJ. 2024;385:q1295.
    PubMed        
  18. FEINMANN J
    Analysis reveals global post-covid surge in infectious diseases.
    BMJ. 2024;385:q1348.
    PubMed        
  19. LAUNER J
    John Launer: Faces or candlesticks? Why we need continuity in teams.
    BMJ. 2024;385:q1323.
    PubMed        
  20. O’DOWD A
    World is woefully unprepared for another pandemic, experts warn.
    BMJ. 2024;385:q1355.
    PubMed        
  21. OLIVER D
    David Oliver: Will the actions pledged in Labour’s election manifesto save health and social care?
    BMJ. 2024;385:q1326.
    PubMed        
  22. BUSE K, McKee M
    UK political parties pledge to strengthen security-yet ignore health security.
    BMJ. 2024;385:q1359.
    PubMed        
  23. ENRIA L, Dwyer H, Marchant M, Beckmann N, et al
    Political dimensions of misinformation, trust, and vaccine confidence in a digital age.
    BMJ. 2024;385:e079940.
    PubMed        
  24. VISWANATH K, Lee EJ, Dryer E
    Communication inequalities and incomplete data hinder understanding of how social media affect vaccine uptake.
    BMJ. 2024;385:e076478.
    PubMed        
  25. FEINMANN J
    GP who confronted Rishi Sunak received “hundreds” of supportive messages from doctors.
    BMJ. 2024;385:q1375.
    PubMed        
  26. LIMB M
    Avoidable mortality in England and Wales remains higher than before pandemic, data show.
    BMJ. 2024;385:q1370.
    PubMed        
  27. NOLAN T
    Avian flu virus in raw milk … and other research.
    BMJ. 2024;385:q1331.
    PubMed        
  28. IACOBUCCI G
    Junior doctors offer prime minister “final chance” to avoid pre-election strike.
    BMJ. 2024;385:q1367.
    PubMed        


    Drug Saf
  29. GORDILLO-MARANON M, Candore G, Hedenmalm K, Browne K, et al
    Lessons Learned on Observed-to-Expected Analysis Using Spontaneous Reports During Mass Vaccination.
    Drug Saf. 2024;47:607-615.
    PubMed         Abstract available


    J Clin Microbiol
  30. YU S-H, Kim K-J, Lee C-C, Puebla YP, et al
    Performance evaluation of the Panbio COVID-19/Flu A&B Panel for detection of SARS-CoV-2, influenza A, and influenza B antigens using mid-turbinate nasal swabs.
    J Clin Microbiol. 2024 Jun 18:e0020724. doi: 10.1128/jcm.00207.
    PubMed         Abstract available


    J Infect
  31. HALVORSEN B, Viermyr HK, Ueland T, Sagen EL, et al
    IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement.
    J Infect. 2024 May 6:106176. doi: 10.1016/j.jinf.2024.106176.
    PubMed        
  32. KIRSEBOM FCM, Stowe J, Lopez Bernal J, Allen A, et al
    Effectiveness of Autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study.
    J Infect. 2024 May 6:106177. doi: 10.1016/j.jinf.2024.106177.
    PubMed         Abstract available
  33. AMANO M, Ichikawa Y, Matsumoto S, Higashi-Kuwata N, et al
    Neutralization activity of HCWs’ sera after Omicron XBB.1.5-adapted monovalent COVID-19 mRNA vaccination.
    J Infect. 2024;89:106179.
    PubMed        
  34. YANG X, Li X, Qiu S, Liu C, et al
    Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: a systematic review and meta-analysis of aggregated participant data.
    J Infect. 2024 May 14:106183. doi: 10.1016/j.jinf.2024.106183.
    PubMed         Abstract available
  35. MOKRANI D, Le Hingrat Q, Thy M, Choquet C, et al
    Clinical characteristics and outcomes of respiratory syncytial virus-associated ARF in immunocompetent patients: A seven-year experience at a tertiary hospital in France.
    J Infect. 2024;89:106180.
    PubMed         Abstract available
  36. HAN B, Li XM, Li R, Ning W, et al
    Epidemiological Surveillance of Acute Respiratory Infections Based on Targeted Metagenomic Next Generation Sequencing During the Flu Season after COVID-19 Pandemic in Beijing.
    J Infect. 2024 May 22:106188. doi: 10.1016/j.jinf.2024.106188.
    PubMed        
  37. ZHAI K, Dong J, Zeng J, Cheng P, et al
    Global Antigenic Landscape and Vaccine Recommendation Strategy for Low Pathogenic Avian Influenza A(H9N2) Viruses.
    J Infect. 2024 Jun 18:106199. doi: 10.1016/j.jinf.2024.106199.
    PubMed         Abstract available


    J Virol Methods
  38. MORECCHIATO F, Coppi M, Niccolai C, Antonelli A, et al
    Evaluation of different molecular systems for detection and quantification of SARS-CoV-2 RNA from wastewater samples.
    J Virol Methods. 2024;328:114956.
    PubMed         Abstract available


    JAMA
  39. HARRIS E
    Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8628.
    PubMed        
  40. HARRIS E
    Lower Dose of Mpox Vaccine Was Safe, Effective.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
    PubMed        


    Lancet
  41. ZAROCOSTAS J
    Mental health in emergencies requires “a major rethink”.
    Lancet. 2024;403:2582.
    PubMed        
  42. AHSAN S
    Israel border closure denying health care to Gazans.
    Lancet. 2024;403:2581.
    PubMed        
  43. SAMARASEKERA U
    African vaccine manufacturing scheme to boost production.
    Lancet. 2024;403:2579-2580.
    PubMed        
  44. KUNKLER I
    Improving future UK pandemic management structure.
    Lancet. 2024;403:2592.
    PubMed        
  45. YOON JH, Kwon IH, Park HW
    The South Korean health-care system in crisis.
    Lancet. 2024;403:2589.
    PubMed        
  46. THE LANCET
    Taking persistent physical symptoms seriously.
    Lancet. 2024;403:2565.
    PubMed        


    N Engl J Med

  47. Are We Prepared for Bird Flu?: ITT Episode 32.
    N Engl J Med. 2024;390:e59.
    PubMed        


    PLoS Comput Biol
  48. ROJAS CHAVEZ RA, Fili M, Han C, Rahman SA, et al
    Mapping the Evolutionary Space of SARS-CoV-2 Variants to Anticipate Emergence of Subvariants Resistant to COVID-19 Therapeutics.
    PLoS Comput Biol. 2024;20:e1012215.
    PubMed         Abstract available


    PLoS One
  49. LIMA HS, Tupinambas U, Guimaraes FG
    Estimating time-varying epidemiological parameters and underreporting of Covid-19 cases in Brazil using a mathematical model with fuzzy transitions between epidemic periods.
    PLoS One. 2024;19:e0305522.
    PubMed         Abstract available
  50. KOLIVAND P, Saberian P, Arabloo J, Behzadifar M, et al
    Impact of COVID-19 pandemic on road traffic injuries in Iran: An interrupted time-series analysis.
    PLoS One. 2024;19:e0305081.
    PubMed         Abstract available
  51. POTTECHER J, Raffi F, Jandrot-Perrus M, Binay S, et al
    Targeting GPVI with glenzocimab in COVID-19 patients: Results from a randomized clinical trial.
    PLoS One. 2024;19:e0302897.
    PubMed         Abstract available
  52. GORGELS KMF, Mujakovic S, Stallenberg E, Hackert VH, et al
    Implementation and effectiveness of non-pharmaceutical interventions, including mask mandates and ventilation, on SARS-CoV-2 transmission (alpha variant) in primary schools in the Netherlands.
    PLoS One. 2024;19:e0305195.
    PubMed         Abstract available
  53. WANG S, Ren J, Guo X
    A high-accuracy lightweight network model for X-ray image diagnosis: A case study of COVID detection.
    PLoS One. 2024;19:e0303049.
    PubMed         Abstract available
  54. LENNOX C, Duncan-Zaleski M, Nasim S, Shirley O, et al
    The impact of the COVID-19 pandemic for children in custody: An analysis of inspection reports.
    PLoS One. 2024;19:e0304862.
    PubMed         Abstract available
  55. REED DS, McElroy AK, Barbeau DJ, McMillen CM, et al
    No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model.
    PLoS One. 2024;19:e0290909.
    PubMed         Abstract available
  56. ZAIDAN M, Puebla Neira D, Polychronopoulou E, Yong-Fang K, et al
    Healthcare utilization 9 months pre- and post- COVID-19 hospitalization among patients discharged alive.
    PLoS One. 2024;19:e0303509.
    PubMed         Abstract available
  57. CHERVO TC, Elkin EP, Nugent JR, Valice E, et al
    Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system.
    PLoS One. 2024;19:e0303303.
    PubMed         Abstract available
  58. DONAGHY R, Shinskey J, Tsakiris M
    Maternal interoceptive focus is associated with greater reported engagement in mother-infant stroking and rocking.
    PLoS One. 2024;19:e0302791.
    PubMed         Abstract available
  59. SETO E
    At freedom’s edge: Belief in free will during the COVID-19 pandemic.
    PLoS One. 2024;19:e0303291.
    PubMed         Abstract available
  60. SANDBERG L, Bostrom AM, Hagstromer M, Lindgren C, et al
    Feasibility of the “Preventing functional decline in acutely hospitalized older patients (PREV_FUNC)” study-A three-armed randomized controlled pilot trial.
    PLoS One. 2024;19:e0304570.
    PubMed         Abstract available
  61. ZEBALLOS D, Magno L, Aranha Rossi T, Soares F, et al
    Performance of two rapid antigen tests against SARS-CoV-2 in neighborhoods of socioeconomic vulnerability from a middle-income country.
    PLoS One. 2024;19:e0298579.
    PubMed         Abstract available
  62. SHENEAMER AM, Halawi MH, Al-Qahtani MH
    A hybrid human recognition framework using machine learning and deep neural networks.
    PLoS One. 2024;19:e0300614.
    PubMed         Abstract available
  63. SCHOULTZ M, Mcgrogan C, Carolan C, Macaden L, et al
    Exploring barriers to care home research recruitment during the COVID-19 pandemic: The influence of social media recruitment posts and public sentiment.
    PLoS One. 2024;19:e0303609.
    PubMed         Abstract available
  64. GROVER EN, Buchwald AG, Ghosh D, Carlton EJ, et al
    Does behavior mediate the effect of weather on SARS-CoV-2 transmission? evidence from cell-phone data.
    PLoS One. 2024;19:e0305323.
    PubMed         Abstract available
  65. BASA M, De Vries J, McDonagh D, Comiskey C, et al
    The impact of COVID-19 on non-communicable disease patients in sub-Saharan African countries: A systematic review.
    PLoS One. 2024;19:e0293376.
    PubMed         Abstract available
  66. CHAMPREDON D, Papst I, Yusuf W
    ern: An [Formula: see text] package to estimate the effective reproduction number using clinical and wastewater surveillance data.
    PLoS One. 2024;19:e0305550.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A
  67. KIM H, Park HH, Kim HN, Seo D, et al
    The TOX-RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases.
    Proc Natl Acad Sci U S A. 2024;121:e2319322121.
    PubMed         Abstract available
  68. TORTORICE D, Rappuoli R, Bloom DE
    The economic case for scaling up health research and development: Lessons from the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2024;121:e2321978121.
    PubMed         Abstract available


    Vaccine
  69. CHENG TM, Chen YS, Wei KC, Chang YC, et al
    Assessment of the herpes zoster risk among renal transplant recipients administered the influenza vaccine.
    Vaccine. 2024 Jun 18:S0264-410X(24)00716-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virology
  70. NAVEED A, Yu J, Lawson S, Gao R, et al
    Receptor binding and immunogenic properties of the receptor binding domain of influenza D virus hemagglutinin-esterase-fusion protein expressed from Escherichia coli.
    Virology. 2024;597:110138.
    PubMed         Abstract available


    Virus Res
  71. RIVETTI AV JR, Reischak D, de Oliveira CHS, Otaka JNP, et al
    Phylodynamics of avian influenza A(H5N1) viruses from outbreaks in Brazil.
    Virus Res. 2024;347:199415.
    PubMed         Abstract available

#Coronavirus Disease Research #References (by AMEDEO.com, June 15 2024)


  1. June 15 Highlight.
    Am J Respir Crit Care Med. 2024;209:xl-xlii.
    PubMed        
  2. FEYS S, Cardinali-Benigni M, Lauwers HM, Jacobs C, et al
    Profiling Bacteria in the Lungs of Patients with Severe Influenza Versus COVID-19 with or without Aspergillosis.
    Am J Respir Crit Care Med. 2024 Jun 12. doi: 10.1164/rccm.202401-0145.
    PubMed         Abstract available
  3. SNYDER ME, Kitsios GD
    Lung Transplant Outcomes Keep BUGging us: Acute Cellular Rejection and the Lung Microbiome.
    Am J Respir Crit Care Med. 2024;209:1423-1425.
    PubMed        
  4. WOZNIAK H, Doufle G, Hamilton M, Santangelo E, et al
    Behind the Mask of Intensive Care Unit Healthcare Workers.
    Am J Respir Crit Care Med. 2024 Mar 14. doi: 10.1164/rccm.202402-0350.
    PubMed        


    Ann Intern Med
  5. DUTCHER EG, Epel ES, Mason AE, Hecht FM, et al
    COVID-19 Vaccine Side Effects and Long-Term Neutralizing Antibody Response : A Prospective Cohort Study.
    Ann Intern Med. 2024 Jun 11. doi: 10.7326/M23-2956.
    PubMed         Abstract available


    BMJ
  6. SMITH C
    Infected blood inquiry: justice will only be delivered when all the recommendations are acted upon.
    BMJ. 2024;385:q1256.
    PubMed        
  7. VIZE R
    What are the early election promises on health?
    BMJ. 2024;385:q1258.
    PubMed        
  8. DEAN E
    Why I . . . make free flight aircraft.
    BMJ. 2024;385:q1157.
    PubMed        
  9. KMIETOWICZ Z
    Sixty seconds on . . . flying.
    BMJ. 2024;385:q1266.
    PubMed        
  10. TORJESEN I
    Hospital doctors in Wales to vote on enhanced pay deal for 2023-24.
    BMJ. 2024;385:q1273.
    PubMed        
  11. MAHASE E
    RCP president is asked to resign over handling of physician associates row.
    BMJ. 2024;385:q1291.
    PubMed        
  12. LAL N
    Study on adverse effects following Covaxin stirs heated debate in India.
    BMJ. 2024;385:q1300.
    PubMed        
  13. IACOBUCCI G
    Tories pledge to slash number of NHS managers to fund health spending.
    BMJ. 2024;385:q1297.
    PubMed        
  14. SADGROVE NEE STACEY C
    Help create an opportunity to learn together.
    BMJ. 2024;385:q868.
    PubMed        
  15. SHEPHERD A
    Striking doctors rally in Stormont.
    BMJ. 2024;385:q1280.
    PubMed        
  16. RIMMER A
    Four year medical degree set to launch in 2026, says NHS England.
    BMJ. 2024;385:q1312.
    PubMed        

  17. Seven days in medicine: 5-11 June 2024.
    BMJ. 2024;385:q1278.
    PubMed        
  18. KMIETOWICZ Z
    Labour vows to “fix NHS again” after Tories leave it “broken”.
    BMJ. 2024;385:q1315.
    PubMed        


    Clin Infect Dis
  19. DIAMOND C
    The Belt Parkway.
    Clin Infect Dis. 2024;78:1399-1400.
    PubMed        
  20. FOWLER VG JR, Durack DT, Suty-Selton C, Miro JM, et al
    Reply to Author.
    Clin Infect Dis. 2024;78:1779.
    PubMed        
  21. FUNDERBURG NT, Shive CL, Lederman MM
    Reply to Chen et al.
    Clin Infect Dis. 2024;78:1776-1777.
    PubMed        
  22. EPSTEIN L
    An Ounce of Prevention Is Worth a Pound of Cure: The LEAP Fellowship.
    Clin Infect Dis. 2024;78:1542-1543.
    PubMed        
  23. ROSTAD CA, Atmar RL, Walter EB, Frey S, et al
    A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US
    Clin Infect Dis. 2024 Mar 27:ciae173. doi: 10.1093.
    PubMed         Abstract available
  24. YAN L, Bui D, Li Y, Rajeevan N, et al
    Identifying Veterans Who Benefit From Nirmatrelvir-Ritonavir: A Target Trial Emulation.
    Clin Infect Dis. 2024 Jun 12:ciae202. doi: 10.1093.
    PubMed         Abstract available


    Emerg Infect Dis
  25. ALVAREZ-HERNANDEZ G, Rivera-Rosas CN, Calleja-Lopez JRT, McCormick DW, et al
    Rocky Mountain Spotted Fever Mimicking Multisystem Inflammatory Syndrome in Hospitalized Children, Sonora, Mexico.
    Emerg Infect Dis. 2024;30.
    PubMed         Abstract available


    J Med Virol
  26. KIM H, Kyung S, Park J, Lee H, et al
    Risks of cutaneous immune-related adverse events in long COVID: Multinational cohort studies in South Korea, Japan, and the UK.
    J Med Virol. 2024;96:e29740.
    PubMed         Abstract available
  27. AGUILAR R, Jimenez A, Santano R, Vidal M, et al
    Malaria and other infections induce polyreactive antibodies that impact SARS-CoV-2 seropositivity estimations in endemic settings.
    J Med Virol. 2024;96:e29713.
    PubMed         Abstract available
  28. SHI P, Wang R, Liu E, Deng Y, et al
    Timing patterns of initial respiratory syncytial virus infection and factors influencing disease severity in hospitalized infants with different health status.
    J Med Virol. 2024;96:e29719.
    PubMed         Abstract available
  29. LEE S, Jo H, Lee H, Lee H, et al
    Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO pharmacovigilance database.
    J Med Virol. 2024;96:e29693.
    PubMed         Abstract available


    J Travel Med
  30. WEE LE, Lim JT, Tan JYJ, Malek MIBA, et al
    Dengue versus COVID-19: Comparing the incidence of cardiovascular, neuropsychiatric, and autoimmune complications.
    J Travel Med. 2024 Jun 12:taae081. doi: 10.1093.
    PubMed         Abstract available


    J Virol
  31. ZHU J, Wang Z, Li Y, Zhang Z, et al
    Trimerized S expressed by modified vaccinia virus Ankara (MVA) confers superior protection against lethal SARS-CoV-2 challenge in mice.
    J Virol. 2024 Jun 14:e0052124. doi: 10.1128/jvi.00521.
    PubMed         Abstract available
  32. DAVID SC, Schaub A, Terrettaz C, Motos G, et al
    Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria.
    J Virol. 2024 Jun 13:e0040924. doi: 10.1128/jvi.00409.
    PubMed         Abstract available
  33. LI L, Li H, Qiu Y, Li J, et al
    PA-824 inhibits porcine epidemic diarrhea virus infection in vivo and in vitro by inhibiting p53 activation.
    J Virol. 2024 Jun 12:e0041323. doi: 10.1128/jvi.00413.
    PubMed         Abstract available
  34. ZHANG Y, Yang N, Li Y, Tan C, et al
    Transmissible gastroenteritis virus induces inflammatory responses via RIG-I/NF-kappaB/HIF-1alpha/glycolysis axis in intestinal organoids and in vivo.
    J Virol. 2024;98:e0046124.
    PubMed         Abstract available
  35. MEADE PS, Bandawane P, Bushfield K, Hoxie I, et al
    Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York City.
    J Virol. 2024 May 15:e0062624. doi: 10.1128/jvi.00626.
    PubMed         Abstract available


    JAMA
  36. PIRRACCHIO R, Venkatesh B, Legrand M
    Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review.
    JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.6096.
    PubMed         Abstract available
  37. ABDUL-AZIZ MH, Hammond NE, Brett SJ, Cotta MO, et al
    Prolonged vs Intermittent Infusions of beta-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.
    JAMA. 2024 Jun 12:e249803. doi: 10.1001/jama.2024.9803.
    PubMed         Abstract available
  38. VAN DER LINDEN S, Roozenbeek J
    “Inoculation” to Resist Misinformation.
    JAMA. 2024;331:1961-1962.
    PubMed        


    Lancet
  39. ANIRVAN P
    Blowing in the wind-India’s health data and transparency issues.
    Lancet. 2024;403:2483-2484.
    PubMed        
  40. MOHAPATRA PR
    Responding to India’s data and transparency.
    Lancet. 2024;403:2482-2483.
    PubMed        
  41. HORTON R
    Offline: The system is not working.
    Lancet. 2024;403:2470.
    PubMed        
  42. FILIPPATOS G, Gold MR, Mullens W, Kusano K, et al
    Clinical outcomes of the AdaptResponse trial – Authors’ reply.
    Lancet. 2024;403:2484-2485.
    PubMed        
  43. KOMAMURA K, Iwase M
    Clinical outcomes of the AdaptResponse trial.
    Lancet. 2024;403:2484.
    PubMed        
  44. MCCALL C
    Security concerns threaten Papua New Guinea relief efforts.
    Lancet. 2024;403:2471.
    PubMed        
  45. KELLY P, Lemmens R, Weimar C, Walsh C, et al
    Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.
    Lancet. 2024 Jun 7:S0140-6736(24)00968-1. doi: 10.1016/S0140-6736(24)00968.
    PubMed         Abstract available


    Life Sci
  46. ENDO HM, Bandeca SCS, Olchanheski LR, Schemczssen-Graeff Z, et al
    Probiotics and the reduction of SARS-CoV-2 infection through regulation of host cell calcium dynamics.
    Life Sci. 2024;350:122784.
    PubMed         Abstract available


    N Engl J Med
  47. LIN DY, Du Y, Xu Y, Paritala S, et al
    Durability of XBB.1.5 Vaccines against Omicron Subvariants.
    N Engl J Med. 2024 May 29. doi: 10.1056/NEJMc2402779.
    PubMed        
  48. OWUSU-ANSAH S, Green Rodgers P
    Reviving Hearts – Uniting Communities with Lifesaving Bystander CPR.
    N Engl J Med. 2024;390:2040-2041.
    PubMed        


    Nature
  49. WONG C
    What causes long COVID? Case builds for rogue antibodies.
    Nature. 2024 Jun 13. doi: 10.1038/d41586-024-02010.
    PubMed        


    Radiol Artif Intell
  50. VEIGA-CANUTO D, Fernandez-Paton M, Cerda Alberich L, Jimenez Pastor A, et al
    Reproducibility Analysis of Radiomic Features from T2-weighted MRI after Processing and Segmentation Alternations in Neuroblastoma Tumors.
    Radiol Artif Intell. 2024 Jun 12:e230208. doi: 10.1148/ryai.230208.
    PubMed         Abstract available


    Science
  51. KAISER J
    In testy hearing, Anthony Fauci confronts critics.
    Science. 2024;384:1057.
    PubMed         Abstract available


    Zhonghua Jie He He Hu Xi Za Zhi
  52. ZHANG Z, Zhou M
    [COVID-19 and autoimmune dysregulation: exploring common mechanisms and treatment strategies in interstitial lung disease].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:571-575.
    PubMed         Abstract available
  53. HE LX
    [Pay attention to new evolution trends in the etiology of community-acquired pneumonia in adults].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:576-581.
    PubMed         Abstract available

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO.com, June 15 ’24)

  1. ZHAI G, Fu W, Yuan S, Sun P, et al
    A fusion protein approach to integrate antiviral and anti-inflammatory activities for developing new therapeutics against influenza A virus infection.
    Antiviral Res. 2024 Jun 9:105924. doi: 10.1016/j.antiviral.2024.105924.
    PubMed         Abstract available
  2. LI J, Cui H, Yao Y, Niu J, et al
    Anti-influenza activity of CPAVM1 protease secreted by Bacillus subtilis LjM2.
    Antiviral Res. 2024 Jun 6:105919. doi: 10.1016/j.antiviral.2024.105919.
    PubMed         Abstract available


    BMJ
  3. MAHASE E
    Bird flu: First person with confirmed H5N2 infection dies.
    BMJ. 2024;385:q1260.
    PubMed        
  4. SMITH C
    Infected blood inquiry: justice will only be delivered when all the recommendations are acted upon.
    BMJ. 2024;385:q1256.
    PubMed        
  5. VIZE R
    What are the early election promises on health?
    BMJ. 2024;385:q1258.
    PubMed        
  6. MAHASE E
    Bird flu: Australia records first human case of H5N1.
    BMJ. 2024;385:q1281.
    PubMed        
  7. DEAN E
    Why I . . . make free flight aircraft.
    BMJ. 2024;385:q1157.
    PubMed        
  8. KMIETOWICZ Z
    Sixty seconds on . . . flying.
    BMJ. 2024;385:q1266.
    PubMed        
  9. TORJESEN I
    Hospital doctors in Wales to vote on enhanced pay deal for 2023-24.
    BMJ. 2024;385:q1273.
    PubMed        
  10. MAHASE E
    RCP president is asked to resign over handling of physician associates row.
    BMJ. 2024;385:q1291.
    PubMed        
  11. LAL N
    Study on adverse effects following Covaxin stirs heated debate in India.
    BMJ. 2024;385:q1300.
    PubMed        
  12. IACOBUCCI G
    Tories pledge to slash number of NHS managers to fund health spending.
    BMJ. 2024;385:q1297.
    PubMed        
  13. SADGROVE NEE STACEY C
    Help create an opportunity to learn together.
    BMJ. 2024;385:q868.
    PubMed        
  14. SHEPHERD A
    Striking doctors rally in Stormont.
    BMJ. 2024;385:q1280.
    PubMed        
  15. MAHASE E
    Bird flu: India reports human case of H9N2 in 4 year old.
    BMJ. 2024;385:q1317.
    PubMed        
  16. RIMMER A
    Four year medical degree set to launch in 2026, says NHS England.
    BMJ. 2024;385:q1312.
    PubMed        

  17. Seven days in medicine: 5-11 June 2024.
    BMJ. 2024;385:q1278.
    PubMed        
  18. KMIETOWICZ Z
    Labour vows to “fix NHS again” after Tories leave it “broken”.
    BMJ. 2024;385:q1315.
    PubMed        


    J Clin Microbiol
  19. MARGULIS M, Rohana H, Erster O, Mandelboim M, et al
    Highly sensitive extraction-free saliva-based molecular assay for rapid diagnosis of SARS-CoV-2.
    J Clin Microbiol. 2024;62:e0060024.
    PubMed         Abstract available
  20. POWELL EA, Greninger AL, Marlowe EM, Naccache SN, et al
    Proceedings of the Clinical Microbiology Open 2023: discussions about pandemic preparedness.
    J Clin Microbiol. 2024;62:e0014424.
    PubMed         Abstract available


    J Epidemiol Community Health
  21. RHEAD R, Wels J, Moltrecht B, Shaw RJ, et al
    Long COVID and financial outcomes: evidence from four longitudinal population surveys.
    J Epidemiol Community Health. 2024;78:458-465.
    PubMed         Abstract available


    J Infect Dis
  22. ATTUR M, Petrilli C, Adhikari S, Iturrate E, et al
    Interleukin-1 Receptor Antagonist Gene (IL1RN) Variants Modulate the Cytokine Release Syndrome and Mortality of COVID-19.
    J Infect Dis. 2024;229:1740-1749.
    PubMed         Abstract available
  23. HARTELOH P, van Mechelen R
    Reply to Mattiuzzi and Lippi.
    J Infect Dis. 2024;229:1930.
    PubMed        
  24. MATTIUZZI C, Lippi G
    Historical Comparison Between the Death Rate for Spanish Flu and Coronavirus Disease 2019 in Italy.
    J Infect Dis. 2024;229:1928-1929.
    PubMed        
  25. GAY L, Rouviere MS, Mezouar S, Richaud M, et al
    Vgamma9Vdelta2 T-cells Are Potent Inhibitors of SARS-CoV-2 Replication and Represent Effector Phenotypes in Patients With COVID-19.
    J Infect Dis. 2024;229:1759-1769.
    PubMed         Abstract available
  26. IVERSEN KK, Ronit A, Ahlstrom MG, Nordestgaard BG, et al
    Lung Function Trajectories in Mild COVID-19 With 2-year Follow-up.
    J Infect Dis. 2024;229:1750-1758.
    PubMed         Abstract available
  27. CARROLL TD, Wong T, Morris MK, Di Germanio C, et al
    Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2-Infected Hamsters.
    J Infect Dis. 2024 Jan 12:jiad568. doi: 10.1093.
    PubMed         Abstract available
  28. ZHANG Y, Zhou Y, Chen J, Wu J, et al
    Vaccination Shapes Within-Host SARS-CoV-2 Diversity of Omicron BA.2.2 Breakthrough Infection.
    J Infect Dis. 2023 Dec 27:jiad572. doi: 10.1093.
    PubMed         Abstract available
  29. LACOURSE SM, Wetzler EA, Aurelio MC, Escudero JN, et al
    Hybrid Immunity to SARS-CoV-2 During Pregnancy Provides More Durable Infant Antibody Responses Compared to Natural Infection Alone.
    J Infect Dis. 2024;229:1728-1739.
    PubMed         Abstract available
  30. LIM SY, Kim JW, Kim JY, Kang SW, et al
    The Association Between Antibody Responses and Prolonged Viable Severe Acute Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A Prospective Cohort Study.
    J Infect Dis. 2024;229:1722-1727.
    PubMed         Abstract available


    J Virol
  31. YU M, Li J, Gao W, Li Z, et al
    Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b.
    J Virol. 2024 May 6:e0162423. doi: 10.1128/jvi.01624.
    PubMed         Abstract available
  32. CESAR RAMOS DE JESUS H, Solis N, Machado Y, Pablos I, et al
    Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL(pro) main protease (Mpro) from proteomic identification of P6-P6′ active site specificity.
    J Virol. 2024 May 14:e0004924. doi: 10.1128/jvi.00049.
    PubMed         Abstract available
  33. MA MT, Jiang Q, Chen C-H, Badeti S, et al
    S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice.
    J Virol. 2024 May 20:e0003824. doi: 10.1128/jvi.00038.
    PubMed         Abstract available
  34. MARIZZI C, Ajayi PK, McMahon R, Meade PS, et al
    A community science approach to public health and public trust in science.
    J Virol. 2024 May 29:e0082524. doi: 10.1128/jvi.00825.
    PubMed         Abstract available
  35. DAVID SC, Schaub A, Terrettaz C, Motos G, et al
    Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria.
    J Virol. 2024 Jun 13:e0040924. doi: 10.1128/jvi.00409.
    PubMed         Abstract available


    JAMA
  36. RUBIN R
    Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.7370.
    PubMed        
  37. VAN DER LINDEN S, Roozenbeek J
    “Inoculation” to Resist Misinformation.
    JAMA. 2024;331:1961-1962.
    PubMed        


    Lancet
  38. LAXMINARAYAN R, Impalli I, Rangarajan R, Cohn J, et al
    Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance.
    Lancet. 2024 May 20:S0140-6736(24)00878-X. doi: 10.1016/S0140-6736(24)00878.
    PubMed         Abstract available
  39. ANIRVAN P
    Blowing in the wind-India’s health data and transparency issues.
    Lancet. 2024;403:2483-2484.
    PubMed        
  40. MOHAPATRA PR
    Responding to India’s data and transparency.
    Lancet. 2024;403:2482-2483.
    PubMed        
  41. THE LANCET
    H5N1: international failures and uncomfortable truths.
    Lancet. 2024;403:2455.
    PubMed        
  42. HORTON R
    Offline: The system is not working.
    Lancet. 2024;403:2470.
    PubMed        
  43. FILIPPATOS G, Gold MR, Mullens W, Kusano K, et al
    Clinical outcomes of the AdaptResponse trial – Authors’ reply.
    Lancet. 2024;403:2484-2485.
    PubMed        
  44. KOMAMURA K, Iwase M
    Clinical outcomes of the AdaptResponse trial.
    Lancet. 2024;403:2484.
    PubMed        
  45. MCCALL C
    Security concerns threaten Papua New Guinea relief efforts.
    Lancet. 2024;403:2471.
    PubMed        


    N Engl J Med
  46. KAISER F, Morris DH, Wickenhagen A, Mukesh R, et al
    Inactivation of Avian Influenza A(H5N1) Virus in Raw Milk at 63 degrees C and 72 degrees C.
    N Engl J Med. 2024 Jun 14. doi: 10.1056/NEJMc2405488.
    PubMed        
  47. OWUSU-ANSAH S, Green Rodgers P
    Reviving Hearts – Uniting Communities with Lifesaving Bystander CPR.
    N Engl J Med. 2024;390:2040-2041.
    PubMed        
  48. LIN DY, Du Y, Xu Y, Paritala S, et al
    Durability of XBB.1.5 Vaccines against Omicron Subvariants.
    N Engl J Med. 2024 May 29. doi: 10.1056/NEJMc2402779.
    PubMed        


    PLoS Comput Biol
  49. HILL EM, Petrou S, de Lusignan S, Yonova I, et al
    Correction: Seasonal influenza: Modelling approaches to capture immunity propagation.
    PLoS Comput Biol. 2024;20:e1012213.
    PubMed         Abstract available
  50. RAWSON T, Hinsley W, Sonabend R, Semenova E, et al
    The impact of health inequity on spatial variation of COVID-19 transmission in England.
    PLoS Comput Biol. 2024;20:e1012141.
    PubMed         Abstract available


    PLoS One
  51. AMANI B, Amani B
    Effectiveness and safety of azvudine in COVID-19: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0298772.
    PubMed         Abstract available
  52. KAKEE S, Kanai K, Tsuneki-Tokunaga A, Okuno K, et al
    Difference in TMPRSS2 usage by Delta and Omicron variants of SARS-CoV-2: Implication for a sudden increase among children.
    PLoS One. 2024;19:e0299445.
    PubMed         Abstract available
  53. MORGENSTERN C, Laydon DJ, Whittaker C, Mishra S, et al
    The interaction of disease transmission, mortality, and economic output over the first 2 years of the COVID-19 pandemic.
    PLoS One. 2024;19:e0301785.
    PubMed         Abstract available
  54. BREWER SE, Bertin KB, Suresh K, LoudHawk-Hedgepeth C, et al
    Factors in COVID-19 vaccine uptake in five racial/ethnic Colorado communities: A report from the Colorado CEAL project.
    PLoS One. 2024;19:e0305160.
    PubMed         Abstract available
  55. CHANG O, Levitt A, Khalid M, Kodeeswaran S, et al
    The prevalence of mental health and addiction concerns and factors associated with depression and anxiety during the COVID-19 pandemic in Ontario, Canada: A cross-sectional study.
    PLoS One. 2024;19:e0305229.
    PubMed         Abstract available
  56. WU Y, Namilae S, Srinivasan A, Mubayi A, et al
    Parametric analysis of SARS-CoV-2 dose-response models in transportation scenarios.
    PLoS One. 2024;19:e0301996.
    PubMed         Abstract available
  57. CHEN F, Nakanishi H, Sekizawa Y, Ochi S, et al
    Investigating the causal effects of COVID-19 vaccination on the adoption of protective behaviors in Japan: Insights from a fuzzy regression discontinuity design.
    PLoS One. 2024;19:e0305043.
    PubMed         Abstract available
  58. MOJEBI A, Wu P, Keeping S, Hale B, et al
    Clinical impact of rapid molecular diagnostic tests in patients presenting with viral respiratory symptoms: A systematic literature review.
    PLoS One. 2024;19:e0303560.
    PubMed         Abstract available
  59. IBRAHIM MR, Lyons T
    FaceTouch: Detecting hand-to-face touch with supervised contrastive learning to assist in tracing infectious diseases.
    PLoS One. 2024;19:e0288670.
    PubMed         Abstract available
  60. LEE SH, Ten Cate O, Gottlieb M, Horsley T, et al
    The use of virtual nominal groups in healthcare research: An extended scoping review.
    PLoS One. 2024;19:e0302437.
    PubMed         Abstract available
  61. FAIRCLOUGH SJ, Clifford L, Foweather L, Knowles ZR, et al
    Move Well, Feel Good: Feasibility and acceptability of a school-based motor competence intervention to promote positive mental health.
    PLoS One. 2024;19:e0303033.
    PubMed         Abstract available
  62. DALKY A, Quran TO, Abuhammad S, Al-Faraj HM, et al
    COVID-19 vaccine acceptance and associated factors among pregnant and lactating women attending maternity care clinics in refugee camps in Jordan.
    PLoS One. 2024;19:e0305314.
    PubMed         Abstract available
  63. NJUMA LIBWEA J, Esso L, Njoh AA, Ngwa CH, et al
    Generating the evidence to support the establishment of a Respiratory Syncytial Virus surveillance system in Cameroon: A study protocol.
    PLoS One. 2024;19:e0303468.
    PubMed         Abstract available
  64. YUH WT, Kim J, Kim MS, Kim JH, et al
    Trends in degenerative lumbar spinal surgery during the early COVID-19 pandemic in Republic of Korea: A national study utilizing the national health insurance database.
    PLoS One. 2024;19:e0305128.
    PubMed         Abstract available
  65. ASHCROFT R, Donnelly C, Sheffield P, Lam S, et al
    A qualitative examination of the experiences and perspectives of interprofessional primary health care teams in the distribution of the COVID-19 vaccination in Ontario, Canada.
    PLoS One. 2024;19:e0304616.
    PubMed         Abstract available
  66. AHMED Z, Gu Y, Sinha K, Mutowo M, et al
    A qualitative exploration of the over-the-counter availability of oral contraceptive pills in Australia.
    PLoS One. 2024;19:e0305085.
    PubMed         Abstract available
  67. CHEONG Q, Kazanjian A, Puyat JH
    Easing anxiety symptoms through leisure activities during social isolation: Findings from nationally representative samples.
    PLoS One. 2024;19:e0303585.
    PubMed         Abstract available
  68. OCHWADA-DOYLE FA, Miles N, Hughes JM, Murphy JJ, et al
    Exploring spatio-temporal changes in coastal recreational fisheries and potential links to extreme weather events.
    PLoS One. 2024;19:e0305106.
    PubMed         Abstract available
  69. CHIEN LC, Marquez ER, Smith S, Tu T, et al
    Exploring the role of the social vulnerability index in understanding COVID-19 immunization rates.
    PLoS One. 2024;19:e0302934.
    PubMed         Abstract available
  70. PENG T, Duong KS, Lu JY, Chacko KR, et al
    Incidence, characteristics, and risk factors of new liver disorders 3.5 years post COVID-19 pandemic in the Montefiore Health System in Bronx.
    PLoS One. 2024;19:e0303151.
    PubMed         Abstract available
  71. FEATHERSTONE AB, Mathijssen AJTM, Brown A, Chitlapilly Dass S, et al
    SARS-CoV-2 Delta variant remains viable in environmental biofilms found in meat packaging plants.
    PLoS One. 2024;19:e0304504.
    PubMed         Abstract available
  72. MCHENGA M, Ndasauka Y, Kondowe F, Kainja J, et al
    Mental health is just an Addendum: Assessing stakeholder’s perceptions on COVID-19 and mental health services provision in Malawi.
    PLoS One. 2024;19:e0305341.
    PubMed         Abstract available
  73. CHICOINE N, Schnipper N, Griffin J
    The role of hesitancy and infrastructure in the equity and efficiency of COVID-19 vaccine administration.
    PLoS One. 2024;19:e0304416.
    PubMed         Abstract available
  74. YANG J, Fang H
    Integrating Embodied Social Presence Theory and Process Virtualization Theory to assess business process virtualizability: The mediating role of embodied co-presence.
    PLoS One. 2024;19:e0305423.
    PubMed         Abstract available
  75. TROTTA E, Serio G, Monacis L, Carlucci L, et al
    The effects of the COVID-19 pandemic on Italian primary school children’s learning: A systematic review through a psycho-social lens.
    PLoS One. 2024;19:e0303991.
    PubMed         Abstract available
  76. CHEN LP, Singh-Verdeflor K, Kelly MM, Sklansky DJ, et al
    Disparities in COVID-19 vaccine intentions, testing and trusted sources by household language for children with medical complexity.
    PLoS One. 2024;19:e0305553.
    PubMed         Abstract available
  77. GONZALEZ SUAREZ ML, Mara KC, Rivera CG, Chesdachai S, et al
    Association of renal function with mortality among hospitalized patients treated with remdesivir for COVID-19.
    PLoS One. 2024;19:e0303896.
    PubMed         Abstract available
  78. ETTMAN CK, Cohen GH, Abdalla SM, Hatton CR, et al
    Depression and assets during the COVID-19 pandemic: A longitudinal study of mental health across income and savings groups.
    PLoS One. 2024;19:e0304549.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A
  79. DONKER T, Papathanassopoulos A, Ghosh H, Kociurzynski R, et al
    Estimation of SARS-CoV-2 fitness gains from genomic surveillance data without prior lineage classification.
    Proc Natl Acad Sci U S A. 2024;121:e2314262121.
    PubMed         Abstract available
  80. AFROZ S, Saul S, Dai J, Surman S, et al
    Human parainfluenza virus 3 vaccine candidates attenuated by codon-pair deoptimization are immunogenic and protective in hamsters.
    Proc Natl Acad Sci U S A. 2024;121:e2316376121.
    PubMed         Abstract available
  81. MCGOUGH L, Cobey S
    A speed limit on serial strain replacement from original antigenic sin.
    Proc Natl Acad Sci U S A. 2024;121:e2400202121.
    PubMed         Abstract available


    Vaccine
  82. LI J, Gong L, Li J, Gong Z, et al
    Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthrough infection by booster.
    Vaccine. 2024;42:3751-3755.
    PubMed         Abstract available
  83. SHANI M, Hermesh I, Feldhamer I, Reges O, et al
    The association between BNT162b2 vaccinations and incidence of immune-mediated comorbidities.
    Vaccine. 2024 May 9:S0264-410X(24)00536-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  84. URQUIDI C, Sepulveda-Penaloza A, Valenzuela MT, Ponce A, et al
    Vaccine effectiveness in reducing COVID-19-related hospitalization after a risk-age-based mass vaccination program in a Chilean municipality: A comparison of observational study designs.
    Vaccine. 2024 May 14:S0264-410X(24)00538-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  85. PROSPER P, Rodriguez Puertas R, Guerin DMA, Branda MM, et al
    Computational method for designing vaccines applied to virus-like particles (VLPs) as epitope carriers.
    Vaccine. 2024 May 22:S0264-410X(24)00584-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  86. SOE P, Wong H, Naus M, Muller MP, et al
    mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network.
    Vaccine. 2024 May 6:S0264-410X(24)00535-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virology
  87. GE P, Ross TM
    COBRA HA and NA vaccination elicits long-live protective immune responses against pre-pandemic H2, H5, and H7 influenza virus subtypes.
    Virology. 2024;597:110119.
    PubMed         Abstract available
  88. RZYMSKI P, Niedziela J, Poniedzialek B, Rosinska J, et al
    Humoral anti-SARS-CoV-2 response in patients with different long COVID phenotypes.
    Virology. 2024;596:110118.
    PubMed         Abstract available

#Coronavirus Disease Research #References (by AMEDEO, June 8 ’24)

  1. LE UNP, Chang YJ, Lu CH, Chen Y, et al
    Glycyrrhizic acid conjugates with amino acid methyl esters target the main protease, exhibiting antiviral activity against wild-type and nirmatrelvir-resistant SARS-CoV-2 variants.
    Antiviral Res. 2024;227:105920.
    PubMed         Abstract available
  2. VAN LOY B, Stevaert A, Naesens L
    The coronavirus nsp15 endoribonuclease: a puzzling protein and pertinent antiviral drug target.
    Antiviral Res. 2024 May 31:105921. doi: 10.1016/j.antiviral.2024.105921.
    PubMed         Abstract available


    BMJ
  3. IACOBUCCI G
    Election watch: What are the main parties promising on health?
    BMJ. 2024;385:q1223.
    PubMed        
  4. WU KA
    Breaking the silence and confronting racism on the wards.
    BMJ. 2024;385:q1225.
    PubMed        
  5. TAYLOR L
    WHO member states agree better ways to detect health threats and set new deadline for pandemic treaty.
    BMJ. 2024;385:q1227.
    PubMed        
  6. DYER O
    Fauci is defiant as congressional hearing into covid origins fails to produce smoking gun.
    BMJ. 2024;385:q1231.
    PubMed        
  7. BHARMAL A, Sharma I, Majeed A, Pinder RJ, et al
    Foundation job allocation in the UK.
    BMJ. 2024;385:q1191.
    PubMed        
  8. DYER C
    Infected blood: an appalling medical tragedy.
    BMJ. 2024;385:q1179.
    PubMed        
  9. TOH CH, Buggins E
    Infected Blood Inquiry details failure after failure.
    BMJ. 2024;385:q1220.
    PubMed        
  10. KMIETOWICZ Z
    Value doctors or see NHS crisis worsen, BMA warns in manifesto for next government.
    BMJ. 2024;385:q1233.
    PubMed        
  11. CHRISTIE B
    Research England put politicians’ interests ahead of free speech, says EDI lead in resignation letter.
    BMJ. 2024;385:q1248.
    PubMed        
  12. CAVE E, Farsides B
    The infected blood scandal: lessons for clinical research.
    BMJ. 2024;385:q1205.
    PubMed        
  13. JONES B
    Suspension of former GP climate protester: don’t shoot the messenger.
    BMJ. 2024;385:q1234.
    PubMed        

  14. Seven days in medicine: 29 May to 4 June 2024.
    BMJ. 2024;385:q1221.
    PubMed        


    Clin Infect Dis
  15. BOECKH M, Pergam SA, Limaye AP, Englund J, et al
    How Immunocompromised Hosts Were Left Behind in the Quest to Control the Covid-19 Pandemic.
    Clin Infect Dis. 2024 Jun 3:ciae308. doi: 10.1093.
    PubMed         Abstract available

  16. Correction to: Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019.
    Clin Infect Dis. 2024 Jun 4:ciae257. doi: 10.1093.
    PubMed        
  17. NIMGAONKAR I, Flaherty PW, Oshima MU, Hill JA, et al
    Acute Endothelial Complications Post-Allogeneic Hematopoietic Cell Transplant in Patients with Pre-Cellular Therapy SARS-CoV-2 Infection.
    Clin Infect Dis. 2024 Jun 4:ciae310. doi: 10.1093.
    PubMed        
  18. OLTOLINI C, Travi G, Mikulska M
    The impact of prior COVID-19 on non-infectious endothelial complications following allogeneic hematopoietic stem cell transplantation.
    Clin Infect Dis. 2024 Jun 5:ciae307. doi: 10.1093.
    PubMed        


    Infect Control Hosp Epidemiol
  19. WEBER DJ, Malani AN, Shenoy ES, Banach DB, et al
    Society for Healthcare Epidemiology of America position statement on pandemic preparedness for policymakers: mitigating supply shortages.
    Infect Control Hosp Epidemiol. 2024 Jun 5:1-5. doi: 10.1017/ice.2024.
    PubMed         Abstract available
  20. BANACH DB, Mathew TA, Batshon LJ, Branch-Elliman W, et al
    SHEA position statement on pandemic preparedness for policymakers: building a strong and resilient healthcare workforce.
    Infect Control Hosp Epidemiol. 2024 Jun 5:1-4. doi: 10.1017/ice.2024.
    PubMed         Abstract available
  21. HSU VP, Haessler S, Banach DB, Batshon LJ, et al
    SHEA position statement on pandemic preparedness for policymakers: introduction and overview.
    Infect Control Hosp Epidemiol. 2024 Jun 5:1-3. doi: 10.1017/ice.2024.
    PubMed         Abstract available


    Int J Infect Dis
  22. MAHYUDDIN AP, Swa HLF, Weng R, Zhang J, et al
    COVID-19 vaccination before or during pregnancy results in high, sustained maternal neutralizing activity to SARS-CoV2 wild-type and Delta/Omicron variants of concern, particularly following a booster dose or infection.
    Int J Infect Dis. 2024 May 30:107121. doi: 10.1016/j.ijid.2024.107121.
    PubMed         Abstract available
  23. DE MENDOZA C, Lozano AB, Rando A, Carmen Nieto MD, et al
    The incidence of HIV-2 infection in Spain is declining – a registry data analysis.
    Int J Infect Dis. 2024 May 30:107076. doi: 10.1016/j.ijid.2024.107076.
    PubMed         Abstract available
  24. LOUBET P, Lelievre JD, Francois A, Botelho-Nevers E, et al
    Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: a French nationwide multicenter cohort study – ANRS0001s COV-POPART.
    Int J Infect Dis. 2024 May 31:107110. doi: 10.1016/j.ijid.2024.107110.
    PubMed         Abstract available


    J Infect
  25. JIANG J, Li Y, Jiang Q, Jiang Y, et al
    Early use of oral antiviral drugs and the risk of post COVID-19 syndrome: a systematic review and network meta-analysis.
    J Infect. 2024 Jun 2:106190. doi: 10.1016/j.jinf.2024.106190.
    PubMed         Abstract available


    J Med Virol
  26. SAADE A, Didier Q, Cha L, Garlantezec R, et al
    The prevalence, determinants, and consequences of post-COVID in healthcare workers: A cross-sectional survey.
    J Med Virol. 2024;96:e29725.
    PubMed         Abstract available
  27. JURKOWICZ M, Cohen H, Nemet I, Keller N, et al
    Epidemiological and clinical characteristics of hospitalized human metapneumovirus patients in Israel, 2015-2021: A retrospective cohort study.
    J Med Virol. 2024;96:e29709.
    PubMed         Abstract available
  28. XIONG X, Zheng Z, Liu C, Wang X, et al
    Unveiling the metabolic and coagulation disruptions in SARS-CoV-2-associated acute macular neuroretinopathy: A case-control study.
    J Med Virol. 2024;96:e29714.
    PubMed         Abstract available
  29. SONG K, Ye RZ, Li YY, Gong C, et al
    A Statovirus-like virus from respiratory tracts of patients, China.
    J Med Virol. 2024;96:e29711.
    PubMed         Abstract available


    J Travel Med
  30. KOMAKECH A, Baki KA, Izudi J
    Visa Relaxation Policies and Potential Implications on Public Health in Africa.
    J Travel Med. 2024;31:taae032.
    PubMed        


    J Virol
  31. SHI J, Hu S, Wei H, Zhang L, et al
    Dipeptidyl peptidase 4 interacts with porcine coronavirus PHEV spikes and mediates host range expansion.
    J Virol. 2024 Jun 3:e0075324. doi: 10.1128/jvi.00753.
    PubMed         Abstract available
  32. HU Y, Hao C, Wang D, Guo M, et al
    Porcine deltacoronavirus nucleocapsid protein antagonizes JAK-STAT signaling pathway by targeting STAT1 through KPNA2 degradation.
    J Virol. 2024 Jun 3:e0033424. doi: 10.1128/jvi.00334.
    PubMed         Abstract available


    JAMA
  33. ANGUS DC, Huang AJ, Lewis RJ, Abernethy AP, et al
    The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided.
    JAMA. 2024 Jun 3. doi: 10.1001/jama.2024.4088.
    PubMed         Abstract available


    Lancet
  34. HORTON R
    Offline: UK election-two issues you won’t hear about.
    Lancet. 2024;403:2362.
    PubMed        
  35. TORNINI VA, Fernandez RW, Goldman OV, Suarez J, et al
    DEI infrastructures required for the best science and medicine.
    Lancet. 2024;403:2375.
    PubMed        
  36. SAMARASEKERA U
    Calls for a focus on health risks in EU election.
    Lancet. 2024;403:2364.
    PubMed        
  37. WATTS G
    Martin Raw.
    Lancet. 2024;403:2372.
    PubMed        


    Lancet Infect Dis
  38. DE LUSIGNAN S, Shi T, Fowler T, Andrews N, et al
    Sleeper frameworks for Pathogen X: surveillance, risk stratification, and the effectiveness and safety of therapeutic interventions.
    Lancet Infect Dis. 2024 Jun 3:S1473-3099(24)00352.
    PubMed        


    Life Sci
  39. HSIEH MS, Chen MY, Chang YS, Huang CS, et al
    Targeting the Neuropilin-1 receptor with Ovatodiolide and progress in using periodontal ligament organoids for COVID-19 research and therapy.
    Life Sci. 2024 Jun 3:122764. doi: 10.1016/j.lfs.2024.122764.
    PubMed         Abstract available


    N Engl J Med
  40. BUONSENSO D
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:2034.
    PubMed        
  41. XU L, Huang X, Li Y
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:2034-2035.
    PubMed        
  42. HAMPSHIRE A, Elliott P
    Cognition and Memory after Covid-19 in a Large Community Sample. Reply.
    N Engl J Med. 2024;390:2035.
    PubMed        


    Nature
  43. LENHARO M
    Hope for global pandemic treaty rises – despite missed deadline.
    Nature. 2024 Jun 3. doi: 10.1038/d41586-024-01658.
    PubMed        
  44. KOZLOV M, Wolf L
    ‘Preposterous’: Anthony Fauci denies cover-up of COVID origins during tense hearing.
    Nature. 2024 Jun 3. doi: 10.1038/d41586-024-01657.
    PubMed        
  45. PARK TJ
    Negotiating a pandemic treaty is just the first step – how will countries comply?
    Nature. 2024;630:9.
    PubMed        


    Science
  46. WAI J
    Missed connectionsThe Last Human Job: The Work of Connecting in a Disconnected World Allison J. Pugh Princeton University Press, 2024. 384 pp.
    Science. 2024;384:1075.
    PubMed         Abstract available
  47. GUEDES TB, Pires MM, Garraffoni ARS, Pareja M, et al
    Brazil should prioritize young scientists at home.
    Science. 2024;384:1077.
    PubMed        
  48. COHEN J
    Global pandemic treaty stalls, again, over equity concerns.
    Science. 2024;384:1054.
    PubMed         Abstract available


    Travel Med Infect Dis
  49. KOISO S, Gulbas E, Dike L, Mulroy NM, et al
    Modeling approaches to inform travel-related policies for COVID-19 containment: a scoping review and future directions.
    Travel Med Infect Dis. 2024 Jun 1:102730. doi: 10.1016/j.tmaid.2024.102730.
    PubMed         Abstract available

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, June 8 ’24)

  1. COLLAMORE G, DiCorcia MJ, Nagpal Y, Fiedler L, et al
    Guidance for Healthcare Providers on Newest Guidelines for Over-the-Counter Drug Treatment of Mild Symptoms of COVID-19.
    Am J Med. 2024;137:490-493.
    PubMed         Abstract available
  2. WU Y, Sawano M, Wu Y, Shah RM, et al
    Factors Associated With Long COVID: Insights From Two Nationwide Surveys.
    Am J Med. 2024;137:515-519.
    PubMed         Abstract available
  3. TAN BJ, Lo YL, Chan LL, Tan EK, et al
    Re-Emergence of Childhood Restless Legs Syndrome in Adulthood Following COVID-19 Infection.
    Am J Med. 2024;137:e109-e110.
    PubMed        
  4. WINGO MT, Andersen CA, Bornstein SL, Huber JM, et al
    Update in Outpatient General Internal Medicine: Practice-Changing Evidence Published in 2023.
    Am J Med. 2024;137:494-499.
    PubMed         Abstract available
  5. QUAN SF, Weaver MD, Czeisler ME, Barger LK, et al
    Association of Obstructive Sleep Apnea with Post-Acute Sequelae of SARS-CoV-2 Infection.
    Am J Med. 2024;137:529-537.
    PubMed         Abstract available


    Biochem Biophys Res Commun
  6. TACHIBANA K, Nakamura Y, Do TL, Kihara T, et al
    Mutations in the SARS-CoV-2 spike proteins affected the ACE2-binding affinity during the development of Omicron pandemic variants.
    Biochem Biophys Res Commun. 2024;719:150120.
    PubMed         Abstract available


    BMJ
  7. LOOI MK
    Bird flu: US confirms first case with respiratory symptoms.
    BMJ. 2024;385:q1203.
    PubMed        
  8. IACOBUCCI G
    Election watch: What are the main parties promising on health?
    BMJ. 2024;385:q1223.
    PubMed        
  9. WU KA
    Breaking the silence and confronting racism on the wards.
    BMJ. 2024;385:q1225.
    PubMed        
  10. DYE C, Barclay WS
    Should we worry about a growing threat from “bird flu”?
    BMJ. 2024;385:q1199.
    PubMed        
  11. TAYLOR L
    WHO member states agree better ways to detect health threats and set new deadline for pandemic treaty.
    BMJ. 2024;385:q1227.
    PubMed        
  12. DYER O
    Fauci is defiant as congressional hearing into covid origins fails to produce smoking gun.
    BMJ. 2024;385:q1231.
    PubMed        
  13. BHARMAL A, Sharma I, Majeed A, Pinder RJ, et al
    Foundation job allocation in the UK.
    BMJ. 2024;385:q1191.
    PubMed        
  14. DYER C
    Infected blood: an appalling medical tragedy.
    BMJ. 2024;385:q1179.
    PubMed        
  15. TOH CH, Buggins E
    Infected Blood Inquiry details failure after failure.
    BMJ. 2024;385:q1220.
    PubMed        
  16. KMIETOWICZ Z
    Value doctors or see NHS crisis worsen, BMA warns in manifesto for next government.
    BMJ. 2024;385:q1233.
    PubMed        
  17. CHRISTIE B
    Research England put politicians’ interests ahead of free speech, says EDI lead in resignation letter.
    BMJ. 2024;385:q1248.
    PubMed        
  18. CAVE E, Farsides B
    The infected blood scandal: lessons for clinical research.
    BMJ. 2024;385:q1205.
    PubMed        
  19. JONES B
    Suspension of former GP climate protester: don’t shoot the messenger.
    BMJ. 2024;385:q1234.
    PubMed        

  20. Seven days in medicine: 29 May to 4 June 2024.
    BMJ. 2024;385:q1221.
    PubMed        


    J Immunol
  21. HE Z, Li W, Zhang M, Huang M, et al
    RNF216 Inhibits the Replication of H5N1 Avian Influenza Virus and Regulates the RIG-I Signaling Pathway in Ducks.
    J Immunol. 2024 Jun 3:ji2300540. doi: 10.4049/jimmunol.2300540.
    PubMed         Abstract available


    J Infect
  22. CAI J, Lai L, Li R, Lin Q, et al
    The H5 subtype of avian influenza virus jumped across species to humans – a view from China.
    J Infect. 2024 Jun 1:106193. doi: 10.1016/j.jinf.2024.106193.
    PubMed        


    J Virol Methods
  23. ZHOU H, Li H, Sun X, Lin J, et al
    Rapid diagnosis of Canine respiratory coronavirus, Canine influenza virus, Canine distemper virus and Canine parainfluenza virus with a Taqman probe-based multiplex real-time PCR.
    J Virol Methods. 2024 May 30:114960. doi: 10.1016/j.jviromet.2024.114960.
    PubMed         Abstract available


    JAMA
  24. ABBASI J
    Bird Flu Outbreak in Dairy Cows Is Widespread, Raising Public Health Concerns.
    JAMA. 2024;331:1789-1791.
    PubMed        


    Lancet
  25. WATTS G
    Martin Raw.
    Lancet. 2024;403:2372.
    PubMed        
  26. SAMARASEKERA U
    Calls for a focus on health risks in EU election.
    Lancet. 2024;403:2364.
    PubMed        
  27. TORNINI VA, Fernandez RW, Goldman OV, Suarez J, et al
    DEI infrastructures required for the best science and medicine.
    Lancet. 2024;403:2375.
    PubMed        
  28. HORTON R
    Offline: UK election-two issues you won’t hear about.
    Lancet. 2024;403:2362.
    PubMed        


    N Engl J Med
  29. BUONSENSO D
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:2034.
    PubMed        
  30. XU L, Huang X, Li Y
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:2034-2035.
    PubMed        
  31. HAMPSHIRE A, Elliott P
    Cognition and Memory after Covid-19 in a Large Community Sample. Reply.
    N Engl J Med. 2024;390:2035.
    PubMed        


    Pediatrics

  32. Successes and Lessons Learned in Responding to the Needs of Pediatricians, Children, and Families During the COVID-19 Pandemic.
    Pediatrics. 2024;153:e2024066634.
    PubMed         Abstract available
  33. PRICE AMH, Measey MA, Hoq M, Rhodes A, et al
    Caregiver and Child Mental Health During 3 Years of the COVID-19 Pandemic.
    Pediatrics. 2024;153:e2023064658.
    PubMed         Abstract available
  34. BURNS JE, Dahlen A, Bio LL, Chamberlain LJ, et al
    Prescribing Patterns of Nonrecommended Medications for Children With Acute COVID-19.
    Pediatrics. 2024;153:e2023065003.
    PubMed         Abstract available


    PLoS One
  35. LEE H, Kennedy CJ, Tu A, Restivo J, et al
    Patterns and correlates of mental healthcare utilization during the COVID-19 pandemic among individuals with pre-existing mental disorder.
    PLoS One. 2024;19:e0303079.
    PubMed         Abstract available
  36. KHORAMJOO M, Wang K, Srinivasan K, Gheblawi M, et al
    Plasma taurine level is linked to symptom burden and clinical outcomes in post-COVID condition.
    PLoS One. 2024;19:e0304522.
    PubMed         Abstract available
  37. OLIVEIRA MDS, Carvalho RF, Meurer CM, Rodrigues EM, et al
    Prevalence, under-reporting, and epidemiological surveillance of COVID-19 in the Araguaina City of Brazil.
    PLoS One. 2024;19:e0300191.
    PubMed         Abstract available
  38. STANISLAWEK WL, Tana T, Rawdon TG, Cork SC, et al
    Avian influenza viruses in New Zealand wild birds, with an emphasis on subtypes H5 and H7: Their distinctive epidemiology and genomic properties.
    PLoS One. 2024;19:e0303756.
    PubMed         Abstract available
  39. DAYAN RR, Blau M, Taylor J, Hasidim A, et al
    Lung ultrasound is associated with distinct clinical phenotypes in COVID-19 ARDS: A retrospective observational study.
    PLoS One. 2024;19:e0304508.
    PubMed         Abstract available
  40. SILVA AAPD, Reis RS, Iachecen F, Duarte F, et al
    First year of COVID-19 in Brazil: Factors associated with the spread of COVID-19 in small and large cities.
    PLoS One. 2024;19:e0298826.
    PubMed         Abstract available
  41. MAGNUS KD, Dammann N, Ziegler E, Ludecke D, et al
    Political party affiliation, social identity cues, and attitudes about protective mask-wearing during the COVID-19 pandemic in Germany.
    PLoS One. 2024;19:e0302399.
    PubMed         Abstract available
  42. AGARWAL A, Canfield C
    Analysis of rural broadband adoption dynamics: A theory-driven agent-based model.
    PLoS One. 2024;19:e0302146.
    PubMed         Abstract available
  43. VARMA JK, Zang C, Carton TW, Block JP, et al
    Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER program.
    PLoS One. 2024;19:e0282451.
    PubMed         Abstract available
  44. GLEESON H, Earnshaw J, Craig C, Hodson C, et al
    Evaluation of the impact of the COVID-19 pandemic on a smoking cessation service in Derbyshire: An interrupted time series analysis.
    PLoS One. 2024;19:e0303876.
    PubMed         Abstract available
  45. SASSE K, Mahabir R, Gkountouna O, Crooks A, et al
    Understanding the determinants of vaccine hesitancy in the United States: A comparison of social surveys and social media.
    PLoS One. 2024;19:e0301488.
    PubMed         Abstract available
  46. BINSWANGER IA, Palmer-Toy DE, Barrow JC, Narwaney KJ, et al
    Assessing the association between antibody status and symptoms of long COVID: A multisite study.
    PLoS One. 2024;19:e0304262.
    PubMed         Abstract available
  47. BUTT AA, Yan P, Shaikh OS
    Nirmatrelvir/ritonavir or Molnupiravir for treatment of non-hospitalized patients with COVID-19 at risk of disease progression.
    PLoS One. 2024;19:e0298254.
    PubMed         Abstract available
  48. SAMOUR A, AlGhazali A, Gadoiu M, Banuta M, et al
    Capital structure and financial performance of China’s energy industry: What can we infer from COVID-19?
    PLoS One. 2024;19:e0300936.
    PubMed         Abstract available
  49. IVYNIAN SE, Maccallum F, Chang S, Breen LJ, et al
    Support needs of Australians bereaved during the COVID-19 pandemic: A cross-sectional survey study.
    PLoS One. 2024;19:e0304025.
    PubMed         Abstract available
  50. REYGAERTS H, Smith S, Renner LM, Ruiz Y, et al
    A qualitative content analysis of cannabis-related discussions on Reddit during the COVID-19 pandemic.
    PLoS One. 2024;19:e0304336.
    PubMed         Abstract available
  51. LE TT, Liao X
    Two-part predictive modeling for COVID-19 cases and deaths in the U.S.
    PLoS One. 2024;19:e0302324.
    PubMed         Abstract available
  52. MUCHANGI JM, Munai D, Moraro R, Thorseth AH, et al
    Lessons from the deployment and management of public handwashing stations in response to the COVID-19 pandemic in Kenya: A cross-sectional, observational study.
    PLoS One. 2024;19:e0303073.
    PubMed         Abstract available
  53. GARG N, Tellier G, Vale N, Kluge J, et al
    Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults.
    PLoS One. 2024;19:e0303450.
    PubMed         Abstract available
  54. BARI A, Alam MR, Islam S, Islam MN, et al
    Proximal tubular dysfunction as a predictor of AKI in Hospitalized COVID-19 patients.
    PLoS One. 2024;19:e0298408.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A
  55. GUO YT, Jiang JB, Qiao GR, Luo RH, et al
    Pleiotropy of positive selection in ancient ACE2 suggests an alternative hypothesis for bat-specific adaptations to host coronaviruses.
    Proc Natl Acad Sci U S A. 2024;121:e2321619121.
    PubMed         Abstract available
  56. GUILLEN JV, Glaunsinger BA
    SARS-CoV-2 Nsp1 traps RNA in the nucleus to escape immune detection.
    Proc Natl Acad Sci U S A. 2024;121:e2408794121.
    PubMed        


    Vaccine
  57. MCDERMID P, Abdi I, Mustafa K, Blazek K, et al
    Examining the influence of community leaders and other community actors on immunisation practices in Australia: A national cross-sectional study.
    Vaccine. 2024;42:3647-3654.
    PubMed         Abstract available
  58. FENG J, Du Y, Chen L, Su W, et al
    A quadrivalent recombinant influenza Hemagglutinin vaccine induced strong protective immune responses in animal models.
    Vaccine. 2024 Jun 3:S0264-410X(24)00624-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  59. GOBIN S, Sahakyan G, Kusi Appiah M, Manukyan A, et al
    Costs of in- and outpatient respiratory disease and the seasonal influenza vaccination program in Armenia – 2020-2021.
    Vaccine. 2024 Jun 4:S0264-410X(24)00623-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virology
  60. DUCATEZ MF, Wang C, Yang J, Zhao Y, et al
    Infection dynamics of subtype H9N2 low pathogenic avian influenza a virus in turkeys.
    Virology. 2024;596:110124.
    PubMed         Abstract available

#Coronavirus Disease Research #References (by AMEDEO, June 1 ’24)


  1. June 1 Highlight.
    Am J Respir Crit Care Med. 2024;209:xxxvii-xxxviii.
    PubMed        


    BMJ
  2. REYNOLDS C, Naqvi H
    Better use of data can help to prevent future deaths.
    BMJ. 2024;385:q1181.
    PubMed        
  3. LYNN E
    May top picks: politics, psychological safety, and creativity.
    BMJ. 2024;385:q1166.
    PubMed        
  4. TAYLOR L
    Pandemic treaty: panel calls for “reset” to talks as negotiators miss deadline.
    BMJ. 2024;385:q1193.
    PubMed        
  5. LIMB M
    Labour’s pledge to clear NHS waiting list within five years will be tough to achieve, say leaders.
    BMJ. 2024;385:q1186.
    PubMed        
  6. KMIETOWICZ Z
    Junior doctors in England announce five day walkout ahead of general election.
    BMJ. 2024;385:q1183.
    PubMed        
  7. MAHASE E
    GPs could threaten mass resignation over NHS contract.
    BMJ. 2024;385:q1182.
    PubMed        
  8. WISE J
    Improving infection prevention could avoid 750 000 deaths a year, say experts.
    BMJ. 2024;385:q1163.
    PubMed        
  9. DYER O
    Covid-19: South African disclosures reveal secretive world of nations’ vaccine contracts.
    BMJ. 2024;385:q1172.
    PubMed        


    Clin Infect Dis
  10. WOLFE DN, Arangies E, David GL, Armstrong B, et al
    Development of Next-Generation COVID-19 Vaccines: BARDA Supported Phase 2b Study Designs.
    Clin Infect Dis. 2024 May 28:ciae286. doi: 10.1093.
    PubMed         Abstract available
  11. HILL JA, Martens MJ, Young JH, Bhavsar K, et al
    SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study.
    Clin Infect Dis. 2024 May 27:ciae291. doi: 10.1093.
    PubMed         Abstract available


    Int J Infect Dis
  12. REEKIE J, Stovring H, Nielsen H, Johansen IS, et al
    Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2.
    Int J Infect Dis. 2024 May 25:107111. doi: 10.1016/j.ijid.2024.107111.
    PubMed         Abstract available


    Intensive Care Med
  13. OUD L
    Long-term outcomes of critically ill patients with hematological malignancies: what is the impact of the coronavirus disease 2019 pandemic?
    Intensive Care Med. 2024 May 28. doi: 10.1007/s00134-024-07493.
    PubMed        


    J Med Virol
  14. HAN Y, Ma Y, Wang Z, Feng F, et al
    TMPRSS13 promotes the cell entry of swine acute diarrhea syndrome coronavirus.
    J Med Virol. 2024;96:e29712.
    PubMed         Abstract available
  15. BORGOGNA C, Ferrante D, Rosso G, Guglielmetti G, et al
    A prospective humoral immune monitoring study of kidney transplant recipients receiving three doses of SARS-CoV-2 mRNA vaccine.
    J Med Virol. 2024;96:e29710.
    PubMed         Abstract available
  16. PAVIA G, Quirino A, Marascio N, Veneziano C, et al
    Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients.
    J Med Virol. 2024;96:e29708.
    PubMed         Abstract available
  17. KOW CS, Ramachandram DS, Hasan SS, Thiruchelvam K, et al
    Antibiotics in COVID-19: Unveiling disturbing truths through critical scrutiny.
    J Med Virol. 2024;96:e29720.
    PubMed        
  18. CHEN IW, Yu TS, Lin CH, Hung KC, et al
    Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19: A meta-regression analysis.
    J Med Virol. 2024;96:e29718.
    PubMed        


    J Travel Med
  19. TAY M, Lee B, Ismail MH, Yam J, et al
    Usefulness of aircraft and airport wastewater for monitoring multiple pathogens including SARS-CoV-2 variants.
    J Travel Med. 2024 May 30:taae074. doi: 10.1093.
    PubMed         Abstract available


    J Virol
  20. MARIZZI C, Ajayi PK, McMahon R, Meade PS, et al
    A community science approach to public health and public trust in science.
    J Virol. 2024 May 29:e0082524. doi: 10.1128/jvi.00825.
    PubMed         Abstract available
  21. RAHMAN SM, Buchholz DW, Imbiakha B, Jager MC, et al
    Migraine inhibitor olcegepant reduces weight loss and IL-6 release in SARS-CoV-2-infected older mice with neurological signs.
    J Virol. 2024 May 30:e0006624. doi: 10.1128/jvi.00066.
    PubMed         Abstract available
  22. KARMAKAR S, Das Sarma J
    Human coronavirus OC43 infection remodels connexin 43-mediated gap junction intercellular communication in vitro.
    J Virol. 2024 May 31:e0047824. doi: 10.1128/jvi.00478.
    PubMed         Abstract available


    Lancet
  23. THORNTON J
    Infected blood report release marks a day of shame for the UK.
    Lancet. 2024;403:2276-2277.
    PubMed        
  24. LAXMINARAYAN R, Impalli I, Rangarajan R, Cohn J, et al
    Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance.
    Lancet. 2024 May 20:S0140-6736(24)00878-X. doi: 10.1016/S0140-6736(24)00878.
    PubMed         Abstract available
  25. THE LANCET
    Cyberattacks on health care-a growing threat.
    Lancet. 2024;403:2263.
    PubMed        
  26. KIMBALL AB, Jemec GBE, Sayed CJ, Kirby JS, et al
    Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
    Lancet. 2024 May 22:S0140-6736(24)00101-6. doi: 10.1016/S0140-6736(24)00101.
    PubMed         Abstract available
  27. PATERLINI M
    Warnings over Italian health-care devolution.
    Lancet. 2024;403:2279.
    PubMed        


    Lancet Infect Dis
  28. HALL P
    Highlights of ESCMID Global 2024.
    Lancet Infect Dis. 2024;24:e357.
    PubMed        
  29. VENKATESAN P
    Alasdair Macintosh Geddes.
    Lancet Infect Dis. 2024;24:577.
    PubMed        


    Life Sci
  30. PETRY J, Weiser T, Griesbaum L, Schroder K, et al
    1.8-cineole prevents platelet activation and aggregation by activating the cAMP pathway via the adenosine A(2A) receptor.
    Life Sci. 2024 May 27:122746. doi: 10.1016/j.lfs.2024.122746.
    PubMed         Abstract available


    N Engl J Med
  31. WANG JJ, Schonborn L, Warkentin TE, Chataway T, et al
    Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders.
    N Engl J Med. 2024;390:1827-1829.
    PubMed        
  32. HALABI S, Gostin LO, Egbokhare O, Kavanagh MM, et al
    Global Health Law for a Safer and Fairer World.
    N Engl J Med. 2024;390:1925-1931.
    PubMed        


    Nature
  33. HAN Y, Duan X, Yang L, Nilsson-Payant BE, et al
    Author Correction: Identification of SARS-CoV-2 inhibitors using lung and colonic organoids.
    Nature. 2024 May 29. doi: 10.1038/s41586-024-07593.
    PubMed        


    Science
  34. VAN DER LINDEN S, Kyrychenko Y
    A broader view of misinformation reveals potential for intervention.
    Science. 2024;384:959-960.
    PubMed         Abstract available
  35. ALLEN J, Watts DJ, Rand DG
    Quantifying the impact of misinformation and vaccine-skeptical content on Facebook.
    Science. 2024;384:eadk3451.
    PubMed         Abstract available

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, June 1 ’24)

  1. FRANCO-MAY DA, Gomez-Carballo J, Barrera-Badillo G, Cruz-Ortiz MN, et al
    Low antiviral resistance in Influenza A and B viruses isolated in Mexico from 2010 to 2023.
    Antiviral Res. 2024;227:105918.
    PubMed         Abstract available


    Arch Virol
  2. HE L, Cao J, Xie X, Zhang Y, et al
    Effects and mechanism of Qingke Pingchuan granules against influenza virus infection.
    Arch Virol. 2024;169:130.
    PubMed         Abstract available


    BMC Pediatr
  3. AL-KUWARI MG, Mohammed AM, Abdulmajeed J, Al-Romaihi H, et al
    COVID-19 testing, incidence, and positivity trends among school age children during the academic years 2020-2022 in the State of Qatar: special focus on using CDC indicators for community transmission to evaluate school attendance policies and public
    BMC Pediatr. 2024;24:374.
    PubMed         Abstract available


    BMJ
  4. REYNOLDS C, Naqvi H
    Better use of data can help to prevent future deaths.
    BMJ. 2024;385:q1181.
    PubMed        
  5. LYNN E
    May top picks: politics, psychological safety, and creativity.
    BMJ. 2024;385:q1166.
    PubMed        
  6. TAYLOR L
    Pandemic treaty: panel calls for “reset” to talks as negotiators miss deadline.
    BMJ. 2024;385:q1193.
    PubMed        
  7. LIMB M
    Labour’s pledge to clear NHS waiting list within five years will be tough to achieve, say leaders.
    BMJ. 2024;385:q1186.
    PubMed        
  8. KMIETOWICZ Z
    Junior doctors in England announce five day walkout ahead of general election.
    BMJ. 2024;385:q1183.
    PubMed        
  9. MAHASE E
    GPs could threaten mass resignation over NHS contract.
    BMJ. 2024;385:q1182.
    PubMed        
  10. WISE J
    Improving infection prevention could avoid 750 000 deaths a year, say experts.
    BMJ. 2024;385:q1163.
    PubMed        
  11. DYER O
    Covid-19: South African disclosures reveal secretive world of nations’ vaccine contracts.
    BMJ. 2024;385:q1172.
    PubMed        


    Epidemiol Infect
  12. YI B, Patrasova E, Simunkova L, Rost F, et al
    Investigating the cause of a 2021 winter wave of COVID-19 in a border region in eastern Germany: a mixed-methods study, August to November 2021.
    Epidemiol Infect. 2024;152:e87.
    PubMed         Abstract available


    J Infect
  13. SKAARUP KG, Lassen MCH, Modin D, Johansen ND, et al
    The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trials.
    J Infect. 2024;89:106187.
    PubMed         Abstract available


    J Virol
  14. CARTER DM, Darby CA, Johnson SK, Carlock MA, et al
    Retraction for Carter et al., “Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses”.
    J Virol. 2024 May 31:e0183223. doi: 10.1128/jvi.01832.
    PubMed        
  15. CARTER DM, Darby CA, Lefoley BC, Crevar CJ, et al
    Correction for Carter et al., “Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses”.
    J Virol. 2024 May 31:e0181323. doi: 10.1128/jvi.01813.
    PubMed        
  16. HUANG Y, Owino SO, Crevar CJ, Carter DM, et al
    Correction for Huang et al., “N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies”.
    J Virol. 2024 May 31:e0112823. doi: 10.1128/jvi.01128.
    PubMed        


    J Virol Methods
  17. MAK WA, Visser W, Koeleman JGM, Ong DSY, et al
    SARS-CoV-2-specific T cell responses: a comparative analysis between QuantiFERON SARS-CoV-2, T-SPOT.COVID, and an in-house Omicron ELISpot.
    J Virol Methods. 2024;327:114949.
    PubMed         Abstract available
  18. HAMILTON S, Zhu M, Cloney-Clark S, Mayes P, et al
    Validation of a severe acute respiratory syndrome coronavirus 2 microneutralization assay for evaluation of vaccine immunogenicity.
    J Virol Methods. 2024;327:114945.
    PubMed         Abstract available
  19. EDWARDS K, Corocher T, Hersusianto Y, Campbell D, et al
    Heparin-mediated PCR interference in SARS-CoV-2 assays and subsequent reversal with heparinase I.
    J Virol Methods. 2024;327:114944.
    PubMed         Abstract available
  20. VASQUEZ V, Orozco J
    Clinical validation of SARS-CoV-2 electrochemical immunosensor based on the spike-ACE2 complex.
    J Virol Methods. 2024;327:114940.
    PubMed         Abstract available
  21. DOSBAA A, Guilbaud R, Yusti AF, Ferre VM, et al
    RSV-GenoScan: An automated pipeline for whole-genome human respiratory syncytial virus (RSV) sequence analysis.
    J Virol Methods. 2024;327:114938.
    PubMed         Abstract available
  22. OUSSET MJ, Pianciola LA, Mazzeo M, Oteiza JM, et al
    Improved SARS-CoV-2 RNA recovery in wastewater matrices using a CTAB-based extraction method.
    J Virol Methods. 2024;327:114918.
    PubMed         Abstract available


    Lancet
  23. PATERLINI M
    Warnings over Italian health-care devolution.
    Lancet. 2024;403:2279.
    PubMed        
  24. THORNTON J
    Infected blood report release marks a day of shame for the UK.
    Lancet. 2024;403:2276-2277.
    PubMed        
  25. BROWN M, Gerrard J, McDougall C, MacPhail J, et al
    Purpura fulminans in young women with influenza and co-infections.
    Lancet. 2024;403:2290-2291.
    PubMed        
  26. THE LANCET
    Cyberattacks on health care-a growing threat.
    Lancet. 2024;403:2263.
    PubMed        


    MMWR Morb Mortal Wkly Rep
  27. HAUSE AM, Moro PL, Baggs J, Zhang B, et al
    Early Safety Findings Among Persons Aged >/=60 Years Who Received a Respiratory Syncytial Virus Vaccine – United States, May 3, 2023-April 14, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:489-494.
    PubMed        
  28. GARG S, Reed C, Davis CT, Uyeki TM, et al
    Outbreak of Highly Pathogenic Avian Influenza A(H5N1) Viruses in U.S. Dairy Cattle and Detection of Two Human Cases – United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:501-505.
    PubMed        


    N Engl J Med
  29. HALABI S, Gostin LO, Egbokhare O, Kavanagh MM, et al
    Global Health Law for a Safer and Fairer World.
    N Engl J Med. 2024;390:1925-1931.
    PubMed        


    PLoS Comput Biol
  30. MASSEY A, Boennec C, Restrepo-Ortiz CX, Blanchet C, et al
    Real-time forecasting of COVID-19-related hospital strain in France using a non-Markovian mechanistic model.
    PLoS Comput Biol. 2024;20:e1012124.
    PubMed         Abstract available
  31. FOSTER ZSL, Tupper AS, Press CM, Grunwald NJ, et al
    Krisp: A Python package to aid in the design of CRISPR and amplification-based diagnostic assays from whole genome sequencing data.
    PLoS Comput Biol. 2024;20:e1012139.
    PubMed         Abstract available


    PLoS One
  32. KUCZYK C, Munch K, Nohre M, Stephan M, et al
    Development and testing of a questionnaire on the expectations and experiences with wearing face masks in inpatient and day hospitals.
    PLoS One. 2024;19:e0304140.
    PubMed         Abstract available
  33. HUANG W, Ichikohji T
    How dynamic capabilities enable Chinese SMEs to survive and thrive during COVID-19: Exploring the mediating role of business model innovation.
    PLoS One. 2024;19:e0304471.
    PubMed         Abstract available
  34. HABTEMARIAM S, Hery CM, Zhang X, Yu M, et al
    Association between sociodemographics and change in alcohol or tobacco use behaviors during the COVID-19 pandemic.
    PLoS One. 2024;19:e0304111.
    PubMed         Abstract available
  35. CHEN Y, Li H, Lin J, Su Z, et al
    Association between (DeltaPaO2/FiO2)/PEEP and in-hospital mortality in patients with COVID-19 pneumonia: A secondary analysis.
    PLoS One. 2024;19:e0304518.
    PubMed         Abstract available
  36. ABDUL-MUMIN A, Bimpong KA, Cotache-Condor C, Oppong J, et al
    Impact of the COVID-19 pandemic on perinatal care and outcomes: A retrospective study in a tertiary hospital in Northern Ghana.
    PLoS One. 2024;19:e0301081.
    PubMed         Abstract available
  37. LIU N, Li Y, Jiang M, Liu B, et al
    Trade shocks and trade diversion due to epidemic diseases: Evidence from 110 countries.
    PLoS One. 2024;19:e0301828.
    PubMed         Abstract available
  38. TAO W, Zhou JY
    A study on the “Porter Hypothesis” effect of the regulatory measures of the environmental protection tax law in the post-pandemic era.
    PLoS One. 2024;19:e0304636.
    PubMed         Abstract available
  39. RAK A, Matyushenko V, Prokopenko P, Kostromitina A, et al
    A novel immunofluorescent test system for SARS-CoV-2 detection in infected cells.
    PLoS One. 2024;19:e0304534.
    PubMed         Abstract available
  40. NGOMTCHO SCH, Akenji BM, Tchio-Nighie KH, Fokam J, et al
    SARS-CoV-2 active infection and antibodies amongst health personnel during the outbreak in Cameroon: Strengthening the health system for response to future public health emergencies.
    PLoS One. 2024;19:e0304477.
    PubMed         Abstract available
  41. ZHOU K, Robert M, Seegers V, Blanc-Lapierre A, et al
    Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.
    PLoS One. 2024;19:e0304556.
    PubMed         Abstract available
  42. WELLSPRING I, Ganesh K, Kreklewetz K
    Walk-in mental health: Bridging barriers in a pandemic.
    PLoS One. 2024;19:e0302543.
    PubMed         Abstract available
  43. ELGEDAWY GA, Samir M, Elabd NS, Elsaid HH, et al
    Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learning.
    PLoS One. 2024;19:e0302977.
    PubMed         Abstract available
  44. CAO D, Tahir SH, Rizvi SMR, Khan KB, et al
    Exploring the influence of women’s leadership and corporate governance on operational liquidity: The glass cliff effect.
    PLoS One. 2024;19:e0302210.
    PubMed         Abstract available
  45. HEARN R, Selfe J, Cordero MI, Dobbin N, et al
    The effects of person-centred active rehabilitation on symptoms of suspected Chronic Traumatic Encephalopathy: A mixed-methods single case design.
    PLoS One. 2024;19:e0302260.
    PubMed         Abstract available
  46. RAHMAN A, Russell M, Zheng W, Eckrich D, et al
    SARS-CoV-2 infection is associated with an increase in new diagnoses of schizophrenia spectrum and psychotic disorder: A study using the US national COVID cohort collaborative (N3C).
    PLoS One. 2024;19:e0295891.
    PubMed         Abstract available
  47. KIMANI ME, Sarr M
    Association of race/ethnicity and severe housing problems with COVID-19 deaths in the United States: Analysis of the first three waves.
    PLoS One. 2024;19:e0303667.
    PubMed         Abstract available
  48. ARBEL Y, Arbel Y, Kerner A, Kerner M, et al
    Can COVID-19 herd immunity be achieved at a city level?
    PLoS One. 2024;19:e0299574.
    PubMed         Abstract available
  49. YOUSEF CC, Farooq A, Amateau G, Abu Esba LC, et al
    The effect of job and personal demands and resources on healthcare workers’ wellbeing: A cross-sectional study.
    PLoS One. 2024;19:e0303769.
    PubMed         Abstract available
  50. DASARI H, Smyrnova A, Leng J, Ducharme FM, et al
    Feasibility, acceptability, and safety of a novel device for self-collecting capillary blood samples in clinical trials in the context of the pandemic and beyond.
    PLoS One. 2024;19:e0304155.
    PubMed         Abstract available
  51. BREBAN R
    Emergence failure of early epidemics: A mathematical modeling approach.
    PLoS One. 2024;19:e0301415.
    PubMed         Abstract available
  52. ACHEAMPONG E, Husain AA, Dudani H, Nayak AR, et al
    Population infection estimation from wastewater surveillance for SARS-CoV-2 in Nagpur, India during the second pandemic wave.
    PLoS One. 2024;19:e0303529.
    PubMed         Abstract available
  53. PASQUALE DK, Welsh W, Bentley-Edwards KL, Olson A, et al
    Homophily and social mixing in a small community: Implications for infectious disease transmission.
    PLoS One. 2024;19:e0303677.
    PubMed         Abstract available
  54. KEMPTHORNE J, Yogeeswaran K, Sibley CG, Bulbulia JA, et al
    The anatomy of prejudice during pandemic lockdowns: Evidence from a national panel study.
    PLoS One. 2024;19:e0303845.
    PubMed         Abstract available
  55. KLEINAU E, Lamba T, Jaskiewicz W, Gorentz K, et al
    Effectiveness of a chatbot in improving the mental wellbeing of health workers in Malawi during the COVID-19 pandemic: A randomized, controlled trial.
    PLoS One. 2024;19:e0303370.
    PubMed         Abstract available
  56. LE T, Flores M, Omaleki V, Hassani A, et al
    Assessing the impact of institutional mistrust on parental endorsement for COVID-19 vaccination among school communities in San Diego County, California.
    PLoS One. 2024;19:e0295618.
    PubMed         Abstract available
  57. RAKIB MI, Alam MJ, Akter N, Tuhin KH, et al
    Change in hierarchy of the financial networks: A study on firms of an emerging market in Bangladesh.
    PLoS One. 2024;19:e0301725.
    PubMed         Abstract available
  58. VOUTOURI C, Hardin CC, Naranbhai V, Nikmaneshi MR, et al
    Dynamic heterogeneity in COVID-19: Insights from a mathematical model.
    PLoS One. 2024;19:e0301780.
    PubMed         Abstract available
  59. ZHANG EY, Baldwin A, Hundley C, Chang E, et al
    Influence of an extreme event-the COVID-19 pandemic-On establishment of and data collection by a citizen science project.
    PLoS One. 2024;19:e0303429.
    PubMed         Abstract available
  60. ZHAO Y, Liu F, Lin P, Tu Z, et al
    Sleep quality and mental health among Chinese nurses after the COVID-19 pandemic: A moderated model.
    PLoS One. 2024;19:e0295105.
    PubMed         Abstract available
  61. SIMANDJUNTAK DP, Jaenicke EC, Wrenn DH
    Pandemic-induced changes in household-level food diversity and diet quality in the U.S.
    PLoS One. 2024;19:e0300839.
    PubMed         Abstract available
  62. SALMAN M, Zhu Y, Kiran S, Sibt E Ali M, et al
    Corporate social responsibility: A key driver of sustainable development in China’s post-COVID economy.
    PLoS One. 2024;19:e0300209.
    PubMed         Abstract available
  63. BALAMPAMA M, de Walque D, Dow WH, Hemono R, et al
    Influence of COVID-19 on female sex workers in Dar es Salaam, Tanzania: A mixed-methods analysis.
    PLoS One. 2024;19:e0303993.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A
  64. WANG D, Huot M, Mohanty V, Shakhnovich EI, et al
    Biophysical principles predict fitness of SARS-CoV-2 variants.
    Proc Natl Acad Sci U S A. 2024;121:e2314518121.
    PubMed         Abstract available
  65. QU B, Miskey C, Gomer A, Kleinert RDV, et al
    TMPRSS2-mediated SARS-CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution.
    Proc Natl Acad Sci U S A. 2024;121:e2407437121.
    PubMed         Abstract available


    Vaccine
  66. XIE Z, Stallings-Smith S, Patel S, Case S, et al
    COVID-19 booster vaccine uptake and reduced risks for long-COVID: A cross-sectional study of a U.S. adult population.
    Vaccine. 2024 Apr 25:S0264-410X(24)00509-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  67. DORJEE K, Namdon T, Topgyal S, Gyatso U, et al
    Association between Covishield vaccine and menstrual disturbance. Findings from a cross-sectional study among participants of Zero TB cohort in India.
    Vaccine. 2024 Apr 27:S0264-410X(24)00500-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  68. MARINTHE G, Brown G, Cristea M, Kutlaca M, et al
    Predicting vaccination hesitancy: The role of basic needs satisfaction and institutional trust.
    Vaccine. 2024 May 3:S0264-410X(24)00507-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  69. BAGLIVO F, De Angelis L, Magri M, De Nicola I, et al
    The impact of COVID-19 vaccination campaign on pediatric vaccine uptake based on parents’ attitudes towards mandatory and recommended vaccination in Southern Italy.
    Vaccine. 2024 May 3:S0264-410X(24)00513-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  70. CHRISTOU-ERGOS M, Bleicher K, Leask J
    Factors associated with vaccination intention and uptake over time in a sample of older Australians.
    Vaccine. 2024 May 3:S0264-410X(24)00508-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  71. ADINUGROHO I, Stafford T, Bentall RP
    The correlation between conspiracy mentality and vaccine intentions is moderated by social events: Evidence from longitudinal data during COVID-19 pandemic in the UK.
    Vaccine. 2024 May 3:S0264-410X(24)00510-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  72. CARDENAS V, Le Gars M, Truyers C, Ruiz-Guinazu J, et al
    Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study.
    Vaccine. 2024;42:3536-3546.
    PubMed         Abstract available
  73. MARANTOS T, Kyriazopoulou E, Angelakis E, Kitsos D, et al
    Immunogenicity of a seasonal influenza and a pneumococcal polysaccharide vaccine in multiple sclerosis patients under disease modifying therapies: A single-center prospective study.
    Vaccine. 2024 May 24:S0264-410X(24)00617-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virology
  74. BROGAARD L, Heegaard PMH, Larsen LE, Skovgaard K, et al
    Pulmonary MicroRNA expression after heterologous challenge with swine influenza A virus (H1N2) in immunized and non-immunized pigs.
    Virology. 2024;596:110117.
    PubMed         Abstract available
  75. TIAN Y, Deng Z, Chuai Z, Li C, et al
    A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge.
    Virology. 2024;596:110125.
    PubMed         Abstract available


    Virus Res
  76. CHIRUMBOLO S, Franzini M, Tirelli U
    Does PI-ME/CFS recall post-COVID (PASC) syndrome?
    Virus Res. 2024;345:199393.
    PubMed        
  77. CHIEN Y, Huang XY, Yarmishyn AA, Chien CS, et al
    Paracrinal regulation of neutrophil functions by coronaviral infection in iPSC-derived alveolar type II epithelial cells.
    Virus Res. 2024;345:199391.
    PubMed         Abstract available
  78. WANG Y, Yu H, Zhang T, Sun Z, et al
    Associations between genetic mutations in different SARS-CoV-2 strains and negative conversion time of viral RNA among imported cases in Hangzhou: A cross-sectional study.
    Virus Res. 2024;345:199400.
    PubMed         Abstract available
  79. XU C, Wang Z, Yu B, Pan Z, et al
    Simultaneous and ultrafast detection of pan-SARS-coronaviruses and influenza A/B viruses by a novel multiplex real-time RT-PCR assay.
    Virus Res. 2024 May 28:199410. doi: 10.1016/j.virusres.2024.199410.
    PubMed         Abstract available
  80. BAI H, Zhang X, Gong T, Ma J, et al
    A systematic mutation analysis of 13 major SARS-CoV-2 variants.
    Virus Res. 2024;345:199392.
    PubMed         Abstract available
  81. PAYEN SH, Adhikari K, Petereit J, Uppal T, et al
    SARS-CoV-2 superinfection in CD14(+) monocytes with latent human cytomegalovirus (HCMV) promotes inflammatory cascade.
    Virus Res. 2024;345:199375.
    PubMed         Abstract available